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SHAPE-DEPENDENT MOLECULAR RECOGNITION OF SPECIFIC SEQUENCES
OF DNA BY HETEROCYCLIC CATIONS
by
YI MIAO
Under the Direction of Dr. W. David Wilson
ABSTRACT

DB921 and DB911 are biphenyl-benzimidazole-diamidine isomers with a central
para- and meta-substituted phenyl group, respectively. Unexpectedly, linear DB921 has
much stronger binding affinity with DNA than its curved isomer, DB911. This is quite
surprising and intriguing since DB911 has the classical curved shape generally required
for strong minor groove binding while DB921 clearly does not match the groove shape.
Several biophysical techniques including thermal melting (Tm), circular dichroism (CD),
biosensor-surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC)
have been utilized to investigate the interactions between these compounds and DNA.
The structure of the DB921-DNA complex reveals that DB921 binds to DNA with a
reduced twist of the biphenyl for better fit of DB921 into the minor groove. A bound
water molecule complements the curvature of DB921 and contributes for tight binding by
forming H-bonds with both DNA and DB921. Structure-affinity relationship studies of a
series of DB921 analogs show that the benzimidazole group is one of the key groups of
DB921 for its strong binding to the minor groove. Thermodynamic studies show that the
stronger binding of DB921 is due to a more favorable binding enthalpy compared to

DB911 even though the complex formation with DNA for these compounds are all
predominantly entropically driven. DB921 also has more negative heat capacity change
than DB911. The initial studies of inhibition of the interaction between an AT hook
peptide of HMGA proteins and its target DNA by a set of diamidine AT-minor groove
binders using biosensor-SPR technique show that the inhibitory ranking order is
consistent with that of binding affinity and linear-shaped DB921 still has excellent
inhibitory effects. These heterocyclic cations rapidly inhibit the binding of DBD2 peptide
to the DNA and may only block the specific AT binding of the peptide without hindering
the non-specific binding interaction. The results of this project have shown that DB921
represents a new novel effective minor groove binder that does not fit the traditional
model and is a potential inhibitor for DNA/protein complexes.
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shape, Compound curvature, Binding affinity, Binding kinetics,
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Chapter 1
Overview

Specific molecular recognition of DNA by ligands has been of great interest
because of the applications in fundamental studies and practical utilities (1-6). The vital
roles played by DNA in biological systems have made it a promising and effective target
for potential therapeutic drug discovery. The numerous gene sequence information from
human genome and other organism genome projects increases the potential utility of
DNA recognition in chemistry, structural and molecular biology as well as in therapeutic
drug development (7-10).
Rational design of small molecules that selectively target DNA has been a
successful strategy for regulation of gene expression and development of a wide range of
antibiotic, antiprotozoal, antiviral and anticancer drugs (11-16). Although the exact
biological action mechanisms of these effective drugs remain incompletely clear, it has
been thought that the biological activities of these drugs involve binding with critical
target DNA sequences and subsequent interference with DNA replication and
transcription and inhibition of expression of viral genes, microbial genes or cancer genes
(17-20). To design new compounds that can specifically bind to the biological target
DNA with requisite binding affinity that can compete with regulatory proteins, the
interactions between small molecules and DNA have been broadly studied to better
understand the molecular recognition and binding mechanism.
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Small molecules generally interact with DNA through three major binding
interaction modes: electrostatic interaction, intercalation, and groove binding interaction
(21). Electrostatic interactions occur between the positively charged cations and
negatively charged phosphate groups on DNA backbone, and they are weak and
nonspecific. The biologically active molecules mainly interact with DNA by intercalation
or groove binding mode (21, 22).

Intercalation
Typical intercalators, such as ethidium, proflavine and acridine orange, contain a
planar fused aromatic ring system (21). Intercalation involves the insertion of the planar
aromatic ring system between the stacked base pairs of double helix DNA. The
intermolecular interactions between the intercalator and base pairs including van der
Waals and hydrophobic interaction stabilize the complex. This type of binding locally
elongates the DNA helix by separating the stacked base pairs and partially unwinds the
DNA helix at the intercalation site (23, 24). Consequently, it induces the structural
perturbation of the DNA duplex, which might prevent the replication of DNA and inhibit
protein synthesis. Therefore, intercalators have been an important class of potential
antibacterial (25) and antitumor agents (26-28) . Most intercalators show a slight GC base
pair preference or no base pair preference. Although the sequence specificity of
intercalators can be increased by adding side substituents capable of sequence recognition
of major or minor groove, intercalators still have less sequence specificity for recognition
of DNA sequences compared to groove binders (21).
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Minor Groove Binding
Groove binding is significantly more selective than intercalation due to contact
with more base pairs along the groove and sequence dependence of the edges of base
pairs (21). Groove binding occurs when the small molecule fits into groove and interacts
with the base pairs on the floor of groove and the wall of the groove. Although both the
major groove and minor groove can be targeted by ligands, small molecules generally
bind in the DNA minor groove with more specific-recognition likely due to the tighter
and larger contact with narrower groove while many proteins interact with DNA in the
wider major grooves (2, 29). In contrast to distortion of DNA helix caused by
intercalation, minor groove binding usually doesn’t produce large structural perturbation
of DNA helix. Also, compared with intercalating agents containing fused aromatic
heterocyclic rings, minor groove binding agents are generally unfused aromatic
heterocyclic cations (Figure1.1).
Minor groove binders are one of the most extensively studied classes of DNAbinding ligands that have high sequence specificity and they are a significant class of
agents that exhibit antibacterial, antiviral, antiprotozal and antitumor activities (9, 11, 16).
Most minor groove binders possess the binding preference for A/T sequences over G/C
sequences, and the preference of A/T sequences mainly arises from following several
factors (21, 30-32). Firstly, structurally, the minor groove of A/T rich sequence is
narrower than G/C rich sequence. It, thus, provides tighter contact with groove binders,
causing stronger van der Waals interactions. Secondly, the electrostatic potentials in the
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A/T rich regions are more negative than G/C rich regions at the floor of the DNA minor
groove (30, 33). Most minor groove binders are positively charged, and their cationic
nature can be balanced by negatively charged A/T base-pair floor. Thirdly, the exocyclic
2-amino group of guanine sterically blocks the groove binder from gaining close contact
to the GC region floor and hydrogen bonding.
A number of natural and synthetic minor groove binders have been well-studied
(Figure 1.1). The structures of DNA bound with minor-groove binders by X-ray
crystallography, NMR and other biological techniques provide valuable information for
better understanding of the sequence-dependent molecular recognition of DNA minor
groove by small molecules.
Netropsin is a natural product that has shown excellent antibiotic and antiviral
activities in vitro. It contains two pyrrole rings and three amide groups with a cationic
amidine and a guanidine group at each end, which gives a crescent shape (Figure 1.1).
Netropsin is a typical minor groove binding agent with AT base pair preference (1, 6, 21).
A number of crystallographic structures of netropsin bound to AT-rich sequences have
been solved (34-37). The first X-ray crystal structure of the complex obtained by Dickson
and co-workers (35) in 1985 shows that netropsin binds to the minor groove of
d(CGCAATTGCG)2 DNA at central AATT region with a 1:1 stoichiometry. The crescent
shape of netropsin matches the curvature of the minor groove very well. Netropsin snugly
fits in the minor groove and makes tight van der Waals contact with the wall of the
groove. Three amide groups of netropsin serve as hydrogen donors forming hydrogen

6

bonds with N3 of adenine and O2 of thymine of AT base pairs, which read the sequences
of AT base pairs.
Pentamidine (1,5-bis(4-amidinophenoxy)pentane) is a synthetic compound that
has been used in clinical treatment for humans for three pathogenic organisms: human
African trypanosomiasis (HAT), leishmaniasis, and Pneumocystis carinii pneumonia
(PCP) (11, 38). Pentamidine is an aromatic diamidine compound with two phenoxy
groups linked by a five methylene group (Figure 1.1). It binds preferentially to the minor
groove of AT sequence in a similar manner to netropsin. The X-ray structure of
pentamidine bound to d(CGCGAATTCGCG)2 (Figure 1.2) shows that the curvature of
pentamidine matches the minor groove (39). The two phenyl groups are parallel to the
wall of the groove and have close van der Waals contacts. The two amidine groups insert
deeply into the minor groove and form hydrogen bonds with N3 of adenine and O2 of
thymine at the floor of the groove, which recognize the AT base pairs.
Extensive structural and binding studies of AT minor groove binders with DNA
reveal that the major factors contributing to the A/T sequence-specific recognition (29, 32,
35, 40-42) are considered as follows: (1) Hydrogen bonding between the hydrogen donor
group of the groove binder and the N3 atom of adenine and O2 atom of thymine for
specific base pair sequence recognition; (2) crescent shape to complement with the
narrow AT minor groove with close van der Waal contact; (3) hydrophobic interaction
between ligand and the surface of the groove.
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Figure 1.2 The crystal structure of pentamidine bound to d(CGCGAATTCGCG)2 (PDB:
1D64) (39) .

8

Furamidine and Its Biological Significance
Furamidine DB75 (2,5-bis(4-amidinophenyl)furan) (Figure 1.1) synthesized by
Dr. David W. Boykin’s laboratory shows excellent biological activity against a broad
spectrum of protozoal microorganisms such as Trypanosoma rhodesiense, Giardia
lamblia, Plasmodium falciparum as well as Pneumocystis carinii (11, 43-46). An X-ray
crystal structure of DB75 with d(CGCGAATTCGCG)2 DNA duplex obtained by Neidle
and co-workers (47) (Figure 1.3) clearly shows that DB75 binds to the minor groove at
AATT region of the duplex. Like other classical minor groove binders, DB75 has a
crescent shape and fits perfectly in the minor groove (32). The two amidine groups form
hydrogen bonds with O2 of thymine bases at the floor of the groove and two phenyl
groups have van der Waals interactions with the wall of the groove. Biophysical studies
show that release of water and cations from the minor groove causes a significant
favorable entropy contribution to the binding free energy (48).
Many aromatic diamidines have been found to have antiparasitic activity (11, 4951). These compounds all bind to the minor groove of AT sequences. Pentamidine and
berenil exhibit excellent biological activity against protozoal microorganisms.
Pentamidine is the first diamidine that has been used as therapeutic agent for clinical
treatment for patients. Berenil has been used in veterinary medicine for the treatment of
trypanosomiasis. However, both compounds have serious toxicities and have to be
administrated intravenously (11, 16). Furamidine DB75 is a new amidine that has
excellent activity against HAT, PCP and malaria and has very low toxicity. An orally

9

Figure 1.3 The crystal structure of furamidine bound to d(CGCGAATTCGCG)2 (PDB:
227D) (47).
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effective prodrug of DB75, DB289, the diamidoxime derivative, is in Phase II clinical
trials against malaria and PCP, and it successfully passed Phase II clinical trials and is
currently in Phase III clinic trials against HAT (52). After oral administration, DB289 is
rapidly metabolized to active DB75. Diamidines enter parasite cells through effective
transporter proteins, such as P2 transporter (53). Evidences show that the primary target
in trypanosome for DB75 is DNA minicircles containing AT-rich sequence of
mitochondrial kinetoplast (52, 54). The results suggest that binding interaction of DB75
may interfere with the replication of kinetoplast DNA.

Effects of Compound Curvature on Minor Groove Binding
All these diamidines and other classical minor groove binders have crescent shapes that
complement the curvature of the minor groove of DNA duplex to obtain better van der
Waals contact and hydrogen bonding interaction (3, 29, 32, 55) as well as adequate
functional group positioning (56). It has been thought that the compound curvature is a
critical factor for compounds to obtain specific and strong binding to the minor groove.
Netropsin and Hoechst are some typical examples. Their crescent-shaped conformations
match the curvature of the DNA minor groove. Compounds with either too great or too
small a curvature will lose binding strength due to lack of optimized surface contact with
the wall of the minor groove (40, 55). DB555, (Figure 1.4), a structural isomer of DB75,
has a para-substituted terminal amidine group on one phenyl ring. This change of
amidine position gives a different shape to the diamidine compound. It is too curved to
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match the shape of the minor groove. Therefore, it loses the required contact interactions
and consequently reduces the binding specificity and affinity as expected (57). The paraxylene compound is an example with a linear shape. The para-xylene compound has a
relatively linear shape compared to pentamidine and its binding affinity is 10 times lower
compared to meta-xylene analogue (58). Recently, however, a near-linear shape
diamidine compound, CGP 40215A (Figure 1.4), has been reported to have strong
binding affinity with AT rich sequence although it doesn’t have curved shape to match
the minor groove. It has strong binding affinity which is due to favorable linker and
water-mediated interaction (59, 60). The bound water molecule provides the curved
shape to the complex and matches the shape of the minor groove. Importantly, CGP
40215A has excellent biological activity against Trypanosoma brucei (61, 62)

The Objectives of This Dissertation
DNA has long been a target for chemotherapeutic intervention and the action of
many clinically effective drugs involve binding with DNA and subsequent inhibition of
gene transcription and translation. An understanding of why some of these molecules can
bind with high affinity and specificity to certain DNA sequences is essential in the design
of drugs targeted to DNA. Since compounds with non-classical structures might have
different biological activity, it is essential to study more non-classical diamidine minor
groove binders. The objective of this research project is to understand the interactions
between DNA and compounds that have different structural and shape characteristic for
design of new DNA minor groove binding compounds.
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The analogs derived from DB75 have been synthesized by Dr. David W. Boykin’s
laboratory (Figure 1.5). DB293 is a derivative in which one of the phenyl rings of DB75
is replaced by a benzimidazole group, which recognizes the sequence containing GC as a
dimer with positive cooperativity (63, 64). Further modification by changing the furan
ring to phenyl ring gives a pair of structural isomers with two quite different shapes.
DB911 with a central meta-substituted phenyl has a curved shape, while DB921 with a
central para-substituted phenyl has a linear shape. The goals of the project are to study
the effects of shape and structure on the binding interactions, investigate the
thermodynamics of the binding interaction, understand the free energy contribution and
energy driven force for the complex formation, and eventually to start the initial study of
the inhibition of HMGA-DNA interaction by different-shaped small molecules. To
achieve these goals, an array of biophysical techniques, UV-visible spectroscopy, thermal
melting (Tm), circular dichroism (CD), biosensor-surface plasmon resonance (SPR), and
isothermal titration calorimetry (ITC) have been utilized. X-ray crystallographic structure
of the complex obtained from Dr. Stephen Neidle’s laboratory has been used to enhance
the understanding of the complex formation. The interaction mode, binding affinity,
kinetics, and sequence specificity of binding interactions of heterocyclic cations with
DNA have been investigated using Tm, CD, and SPR. Thermodynamics of binding
interactions have been studied using ITC and SPR.
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Chapter 2 discusses the unusual strong binding of a linear-shaped diamidine
DB921 to the minor groove of DNA. The binding affinity, crystallographic structure of
complex (from Dr. Stephen Neidle’s laboratory), and preliminary thermodynamics are
described.
Chapter 3 presents the structure-affinity relationship study of linear-biphenyldiamidine analogs of DB921. The key function groups for DNA sequence recognition
and strong binding are discussed.
Chapter 4 describes the detailed thermodynamic results for the binding of DB921
and its isomers to AT sequence DNA.
Chapter 5 shows the preliminary study on inhibition of the binding interaction
between HMGA protein and DNA by an AT-hook/targeted DNA model system using
biosensor-surface plasmon resonance (SPR) technique.
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Chapter 2
Out-of-Shape DNA Minor Groove Binders: Induced Fit Interactions of
Heterocyclic Dications with the DNA Minor Groove

Introduction
Human African trypanosomiasis (HAT), or sleeping sickness, caused by
eukaryotic Trypanosoma brucei, is one of the most severe parasitic diseases in tropical
Africa. It infects millions of people every year and it is lethal if untreated (1). However,
an effective treatment for this disease is still limited. The currently used drugs were
derived decades ago, and many of them are losing efficacy against drug-resistant
parasites. They require large injection doses and are toxic (2, 3). Therefore, there is an
urgent need for new effective, safe and affordable anti-parasitic drugs.
Aromatic dicationic diamidines have displayed biological activities against a
broad range of parasitic diseases including trypanosomiasis (4). Pentamidine is the first
diamidine compound that has been used in the clinical treatment against trypanosomiasis.
Berenil has been used for treatment of animals. But they have side effects and lack oral
bioavailability. Recently, a new diamidine, furamidine DB75 (Figure 2.1), has shown
very promising therapeutic anti-parasitic activity. Its orally effective prodrug has been
found to have very low toxicity and excellent activity against Human African
trypanosomiasis and malaria. Evidences show that diamidines enter trypanosomes rapidly,
probably due to the effective carrying by membrane transporters such as P2 adenosine
(5). Fluorescence microscopy results indicate that AT rich sequences of mitochondrial
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kinetoplast DNA (kDNA) in trypanosomes are the primary targets for diamidines, and
these diamidines interfere with the replication of kDNA (6).
Most biologically active aromatic dicationic diamidines bind to the minor groove
of AT sequences of DNA (4, 7, 8). Rational design of heterocyclic dications that
selectively target DNA minor groove has been proven to be a promising and effective
strategy for development of new anti-parasitic drugs. Classical minor groove binders
generally contain unfused aromatic rings bonded with torsional freedom, hydrogen donor
or acceptor group, positive charge and crescent shape (9, 10). The crescent shape has
been considered as one of the critical factors for compounds to acquire strong binding
affinity to the DNA minor groove due to full contact with the minor groove by shape
complementarity. The compounds with too curved or linear shape have been found to
have low binding affinities to the minor groove (11, 12). Recently, however, a linearshape diamidine CGP40215A (Figure 2.1), which has excellent activity against
Trypanosoma brucei rhodesiense, was found to bind tightly to AT sequences in spite of
the fact that it does not have the classical curved shape that is normally required for
strong binding (13, 14). The crystal structure of CGP and a DNA duplex containing an
AATT binding site shows that an amidine group located in the groove and an -NH group
in the nitrogen rich linker form direct hydrogen bonds to A·T base pairs in the binding
site. The amidine at the other end of CGP is away from the floor of the groove due to the
lack of curvature but it forms indirect H-bonds with DNA through a bound water
molecule. The bound water forms hydrogen bonds with an amidine group of the ligand
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and A·T base pair groups at the floor of the groove. The water molecule compensates for
the lack of curvature of the linear CGP for minor groove binding.
To further understand the shape dependence of aromatic dicationic diamidine on
binding affinity to DNA minor groove, we have studied a pair of isomeric diamidine
derivatives with different curvatures. These diamidine analogs were derived from DB293,
which recognizes mixed DNA sequences and forms a dimer in the binding site in a
positive cooperative manner (15, 16). In this Chapter, the studies of the binding
interactions of these two isomeric biphenyl-benzimidazole diamidine derivatives with
DNA by using biosensor- surface plasmon resonance, circular dichroism, isothermal
titration microcalorimetry, and X-ray crystallography/molecular modeling methods are
reported. DB911 has a central meta-substituted phenyl that gives it a classical type
curvature similar to that of DB75 and related minor groove binders, whereas DB921 has
a central para-substituted phenyl that gives it a much more linear shape that clearly
cannot match the curvature of the DNA minor groove (Figure 2.1). Surprisingly, we find
that the linear compound DB921 binds to AT sequences in DNA much more strongly
than its curved isomer, DB911. X-ray crystallographic analysis of DB921 bound to an
AATT sequence suggests that, as with CGP40215A (Figure 2.1), a bound water molecule
is able to complete the curvature of DB921 for strong minor groove interactions.
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Materials and Methods
Compounds, DNAs, and Buffers
DB921 and DB911 were synthesized as previous described (17, 18).
Poly(dA)·poly(dT) from Pharmacia Co. was used for Tm experiments. 5’-Biotin labeled
hairpin DNA oligomers were from Midland Certified Reagent Co. with reversed-phase
HPLC purification and mass spectrometry characterization. MES buffers contained 0.01
M MES and 0.001 M EDTA adjusted to pH 6.25. MES00, MES10, and MES20 buffers
contained the above components plus 0, 0.1, and 0.2 M NaCl, respectively.
Thermal Melting (Tm)
Tm experiments were conducted with a Cary 300 UV-Visible spectrophotometer
in 1-cm quartz cuvettes. The absorbance of the DNA-compound complex was monitored
at 260 nm as a function of temperature and DNA without compound was used as a
control. Cuvettes were mounted in a thermal block and the solution temperatures were
monitored by a thermistor in a reference cuvette with a computer controlled heating rate
of 0.5 °C/min. A ratio of 0.3 compound per DNA base was used for the complex with
poly(dA)·poly(dT).
Circular Dichroism (CD)
CD spectra were collected with a Jasco J-710 spectrometer at different ratios of
compound to DNA at 25 ºC in MES10 buffer. The DNA was added to buffer in a 1 cm
quartz cuvette and scanned over a desired wavelength range. The compounds at
increasing ratios were then titrated into DNA and the complexes were rescanned under
same conditions.
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Biosensor - Surface Plasmon Resonance (SPR)
Biosensor-SPR experiments were conducted with a BIAcore 3000 (Biacore,
Uppsala, Sweden) instrument as previously described (13-16). 5’-Biotin labeled DNA
hairpins were immobilized on four channel BIAcore SA sensor chips via non-covalent
streptavidin capture. Three flow cells contained DNA and one flow cell was left blank as
a reference. The compounds at different diluted concentrations in the degassed and
filtered MES 20 buffer with 0.005% BIA certified surfactant P-20 were injected over the
DNA surface for selected times. A glycine solution (10 mM, pH 2.0) was used for
regeneration. Steady-state binding studies were carried out by averaging the resonance
unit values (RU) over a selected time region at different compound concentrations and
converting them to r (moles of bound compound per mole of DNA hairpin), r = RUeq /
RUmax, where RUeq is the averaged RU at steady state for each concentration and RUmax
is the maximum RU value for binding one compound per binding site. The binding
constant, KA, was obtained from the best fit of r versus free compound concentration
(Cfree) with a one site binding model
r = (KA* Cfree) / (1 + KA* Cfree)

(1)

Fits with more than one site did not improve the correlation coefficient or residuals
significantly for either DB921 or DB911. Kinetics analysis was performed by global
fitting of the binding data with non-mass-transport and mass transport limited kinetic 1:1
binding models (19, 20). In the non-mass-transport 1:1 binding model, eq.(2) is used,
while in the mass transport limitation model, eq.(2) and eq.(3) are used.
A + B ↔ AB

KA = [AB]/[A][B] = ka / kd
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[A]t=0 = 0, [B]t=0 = RUmax, [AB]t=0 = 0
d[AB]/dt = ka[A][B] - kd[AB]

(2)

d[A]/dt = kt([Abulk] - [A]) – (ka[A][B] - kd[AB])

(3)

where [A] and [Abulk] are the concentration of the compound at the sensor surface and the
in the bulk solution, respectively, [B] is the concentration of the immobilized DNA
without bound compound, and [AB] is the concentration of the complex; ka is the
association and kd is the dissociation rate constant.
Isothermal Titration Calorimetry (ITC)
ITC experiments were performed with a MicroCal VP-ITC (MicroCal Inc.,
Northampton, MA) interfaced with a computer equipped with VP-2000 viewer
instrument control software. ITC data were analyzed with Origin 5.0 software. In ITC
experiments, 10 µl of compound in MES 20 buffer was injected into the instrument
sample cell containing AATT DNA duplex in MES 20 buffer for each injection. The
observed heat for each injection was measured by integration of the area of power peak
with respect to time. Blank titrations were conducted by injecting the compound into the
sample cell containing only buffer under the same conditions. The corrected interaction
heat was determined by subtracting the blank heat from that for the compound/DNA
titration.
Crystallography (Experiments done by Dr. Stephen Neidle’s laboratory)
DB921 was co-crystallized by the hanging-drop method with the sequence
d(CGCGAATTCGCG)2 from a drop containing 9.375 mM MgCl2, 0.375 mM duplex
DNA, 0.5 mM DB921, 3.125% v/v (±)-2-methyl-2,4-pentanediol (MPD), and 20 mM
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sodium cacodylate buffer at pH 6.5, equilibrated against a reservoir of 50% v/v MPD
solution. The crystals, in space group P212121, were isomorphous with other minorgroove drug structures, and were solved by molecular replacement using 7968 unique
reflections to a resolution of 1.64 Å (96% completeness) collected with an in-house
image plate system on a flash-frozen crystal. The final R factor and Rfree values were
21.4% and 28.5%, with the inclusion of 76 water molecules and a hydrated magnesium
ion. Atomic coordinates and structure factors have been deposited in the Protein data
bank as entry code 2B0K.
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Results and Discussion
Thermal Melting
Thermal melting enables the rapid qualitative evaluation of the relative binding
affinities of compounds to DNA (21). As part of a screen to find new anti-parasitic agents
that target AT sequences of parasite kDNA, ∆Tm values for DB921 and DB911 with
polydA·polydT were compared to that for the well-characterized reference compound,
DB75 (∆Tm = 24.8 °C in MES10 buffer), under the same conditions. Converting the
furan of DB75 to a similarly shaped meta-substituted phenyl group (DB911, ∆Tm = 25.3
°C) does not significantly change the stability of the complex. Surprisingly, however,
changing the central group from a meta to para substituted phenyl (DB921) results in a
significant increase in melting temperature. The binding of DB921 is so strong that the
complex with poly(dA)·poly(dT) DNA unfolds above 95 ºC and no melting transition
was observed (∆Tm > 28 °C) (Figure 2.2). Thermal melting results with an AATT DNA
hairpin duplex with a lower Tm were studied at ratios of 1:1, 2:1 and 3:1 compound:
oligomer duplex (Figure 2.3). The results suggest that DB921 may bind to the AATT
DNA sequence with 1:1 stoichiometry since the Tm does not significantly increase at
ratios above the 1:1 ratio and there is no free DNA Tm peak at 1:1 ratio. The ∆Tm values
for DB911 and DB921 are 19.8 and 25.9 °C, respectively, with the AATT hairpin duplex
as shown in Figure 2.4. ∆Tm values for both compounds were quite low for DNA
sequences that contain only GC base pairs (not shown). These results clearly indicate
DB921 has a binding affinity for A·T DNA sequences that is much greater than expected
based on its molecular structure.
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Figure 2.2 Thermal melting profile for poly(dA)·poly(dT) in the absence and presence of
DB921 and DB911 in MES10 buffer. A molar ratio of 0.3 compound per DNA base was
used for compound/DNA complex.
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Figure 2.3 Thermal melting curves (A) and derivative curves (B) of AATT hairpin DNA
in the absence and presence of different ratios of DB921/DNA hairpin in MES00 buffer.
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Figure 2.4 Thermal melting profile (A) and the plot of the first derivatives of absorbance
with respect to temperature against temperature for AATT hairpin DNA in the absence
(blue) and presence of DB911 (red) and DB921 (green) in MES00 buffer. A
compound/DNA hairpin ratio of 1:1 was used for compound/DNA complex.
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Circular Dichroism
Given the strong binding of DB921 to A·T DNA, a critical question is whether it
has a similar binding mode to DB75 and DB911. To probe the mode of binding, CD
spectra of DB921 and DB911 with the AATT DNA hairpin used in Tm studies were
monitored. At the maximum absorption wavelengths of the compounds, 325 nm (DB921)
and 315 (DB911) nm, where the DNA CD signals do not interfere, positive induced CD
signals were observed (Figure 2.5). Positive induced CD signals are generally a
characteristic of binding in the minor groove of DNA (22, 23). Interestingly, the induced
positive CD signal of DB921 is not as large as for DB911 or as generally expected for
strong binding in the minor groove of AT sequences. Small induced CD changes on
binding to DNA may be a characteristic of linear compounds (14). No significant CD
signals were observed on addition of DB921 or DB911 to GC sequence DNA under the
same conditions (not shown). At much higher concentrations, small induced CD signals
were observed for DB911 with GC sequences, perhaps due to partial intercalation as
observed for DB75 with GC sequences (22). In summary, CD results indicate that both
DB921 and DB911 bind in the DNA minor groove in AT sequences.
Biosensor-Surface plasmon resonance (SPR)
Biosensor-SPR methods provide an excellent way to quantitatively compare the
interactions between small molecules and DNA (24-26). Because of the strong binding
and relatively weak spectroscopic signals of the diamidines at typical experimental
concentrations (typically sub-nM to 1 µM), it is difficult to determine their K values by
spectroscopy. Calorimetric and other potential methods have similar limitations where
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Figure 2.5 CD spectra of DB921 (A) and DB911 (B) with the AATT hairpin duplex in
MES 10 buffer at 25 ºC. The molar ratios of compound to DNA hairpin are 0, 0.2, 0.4,
0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 from the bottom to the top at the induced CD
wavelength maximum.
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strong binding is obtained. Because SPR with immobilized DNA responds to the mass of
the bound species, it can be used for diamidines that have large variations in properties, K
values.
SPR sensorgrams for the binding of DB921 and DB911 with a DNA hairpin
duplex that contains a single AATT binding site (Figure 2.1) are compared in Figure 2.6.
Similar experiments with an oligomer hairpin with only GC base pairs did not show any
detectible binding (not shown). For the steady-state analysis, KA values for DB921 and
DB911 to AATT DNA were determined from the nonlinear least-squares best fit to a
single binding site model (Figure 2.7). For the kinetic data analysis, association rate
constant (ka) and dissociation rate constant (kd) were determined by global fitting of the
binding data (Figure 2.6). The kinetic KA was derived from the ratio of association and
dissociation rate constants (Table 2.1). The interaction kinetics of DB921 with DNA
under the experimental conditions are dominated by mass transport from the bulk
solution to the biosensor interaction matrix. As expected for mass transport limited rates,
the kinetic data are quite different when fitting with mass-transport versus non-masstransport kinetic models, and when changing the flow rate (20). The calculated ratios of
ka RUmax /kt are greater than 5, providing further evidence for mass transport limited
binding rates since the ratio of less than 5 has been shown to be important for obtaining
reliable kinetic data (20). Reliable binding affinities, however, can be obtained from SPR
results under these conditions, and the binding affinity for DB921 derived from the
kinetic model is in good agreement with KA values from steady-state result (Table 2.1).
The binding of DB911 to the AATT hairpin is weaker than for DB921 and, under the

40

30
DB921

25
20

RU

15
10
5
0
-5
0

100

200

300

400

500

600

700

Time (s)

30
DB911
25
20

RU

15
10
5
0
-5
0

40

80

120

160

200

240

280

Time (s)

Figure 2.6 SPR sensorgrams for binding of DB921 (top) and DB911 (bottom) with the
immobilized AATT DNA hairpin in MES20 buffer. The black lines are best fit curves by
global kinetics fitting. For DB921, the concentrations from bottom to top are 0, 0.001,
0.0015, 0.002, 0.003, 0.004, 0.006, 0.008 and 0.01 µM. For DB911, the concentrations
from bottom to top are 0, 0.004, 0.01, 0.02, 0.04, 0.06, 0.1, 0.2, and 0.4 µM.

41

1

0.8

r

0.6

0.4

DB921_AATT
DB911_AATT
8

-1

7

-1

DB921: K = 2.7 × 10 M

0.2

A

DB911: K = 1.9 × 10 M
A

0
0

1 10

-7

2 10

-7

3 10

-7

4 10

-7

5 10

-7

Conc. (M)

Figure 2.7 Binding curves for the interactions of DB911 and DB921 with AATT DNA
hairpin in MES20 buffer at 25 °C. The data were fitted using a one-site binding model
(see Methods).
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experimental conditions of Figure 2.6, is not mass transport limited. For DB911, the
association and dissociation rate constants as well as the KA value (Table 2.1) obtained
from global fits with mass-transport kinetic models are consistent with non-masstransport limited binding kinetics. In summary, SPR results quantitatively demonstrate
that DB921 with a non-classical, linear shape binds very strongly to AATT DNA. Its
binding affinity is over 10 times greater than for that of DB911 and DB75. Both DB921
and DB911 have a single strong binding site on the AATT DNA hairpin.
Isothermal titration calorimetry (ITC)
ITC experiments with an AATT sequence oligomer were conducted to obtain a
full thermodynamic understanding of the DB921 and DB911 interactions as well as the
basis for the exceptionally strong binding of DB921 (27). Titration of DB921 into buffer
and into a DNA solution provided plots of heat versus molar ratio (Figure 2.8). Due to the
strong binding of DB921 and DB911 and the relatively small heats of interaction, only
∆H and not K could be obtained from the ITC experiments. Because of the lower binding
enthalpy for DB911 (Figure 2.9), we have also performed experiments at higher
concentration of DB911 and DNA to improve the results so that the signal-to-noise ratio
was like that with DB921. The observed binding ∆H for DB921 at 25ºC is -4.5 ± 0.1
kcal/mol; the ∆H value for DB911 is significantly lower, -2.5 ± 0.1 kcal/mol. The
calculated -T·∆S values based on the SPR binding free energies (∆G° = -RT lnK = -11.5
kcal/mol for DB921 and -10.0 kcal/mol for DB911) and ∆H values from ITC are -7.0
kcal/mol for DB921 and -7.5 kcal/mol for DB911 (Table 2.2). These results clearly show
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Table 2.1 Binding constant and kinetics of DB921 and DB911 to AATT DNA in MES20
buffer at 25 °C
ka [1/(Ms)]

kd (1/s)

KA (ka/kd) (1/M)

KA (steady-state) (1/M)

DB921

-

-

2.9 × 108

2.7 × 108

DB911

3.26 ×106

0.153

2.1 × 107

1.9 × 107

Table 2.2 Thermodynamic results of binding of DB921 and DB911 to AATT DNA in
MES20 buffer at 25 °C
∆Ga (kcal/mol)

∆H (kcal/mol)

-T∆Sb (kcal/mol)

DB921

-11.5

-4.5

-7.0

DB911

-10.0

-2.5

-7.5

a

Calculated using the average ∆G value from kinetics and steady state, ∆G = -RT lnKA

b

Calculated by equation ∆G = ∆H - T∆S
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Figure 2.8 ITC experimental curves for titration of 0.025 mM DB921 into 0.004 mM
d(GCGAATTCGC)2 duplex (left) and MES20 buffer (right) at 25 ºC. The average heat
per mole of compound between molar ratios of 0.1 to 0.6 was used to calculate ∆H.
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Figure 2.9 ITC experimental curves for titration of 0.025 mM DB911 into 0.004 mM
d(GCGAATTCGC)2 duplex (left) and MES20 buffer (right) at 25 ºC. The average heat
per mole of compound between molar ratios of 0.1 to 0.6 was used to calculate ∆H.
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that the stronger binding of DB921 is entirely due to a more favorable binding enthalpy
compared to DB911.
Although the thermodynamic differences between DB921 and DB911 are
undoubtedly due to a number of factors, the strong similarity of the structural isomers
significantly limits some of the factors. The similarity of the structure of DB911 to
compounds such as DB75, berenil and pentamidine (Figure 2.1) suggests that it will form
a complex with both amidines H-bonded to DNA bases as with the compounds listed
above. DB921, however, requires a connecting water molecule to interact indirectly with
the base pairs at one end of the complex (Figure 2.10). It is interesting that the favorable
∆(∆H) and unfavorable ∆(∆S) values for the differences between binding
thermodynamics of DB921 and DB911 are in the range predicted by Dunitz (28) and
Cooper and coworkers (29, 30) for a bound water in compound-biopolymer complexes.
The ∆(∆H) value is toward the higher end of the estimates, while the ∆(∆S) is at the
lower end, indicating, as expected, that other factors are involved. Certainly at the
qualitative level, however, the observed thermodynamic values support the experimental
and theoretical analyses of Dunitz (28) and Cooper (29) for the influence of a bound
water.
X-ray Crystallography
The crystal structure of the DB921-d(CGCGAATTCGCG)2 complex has one
DB921 molecule binding in the minor groove within the central 5’-AATT region, with
one amidinium group (benzimidazole side) anchored in the groove and the other (phenyl
side) off the groove floor (Figure 2.10). The structure shows that the radius of curvature
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Figure 2.10A Electron-density map calculated with the final refined coordinates and
drawn in the plane of the DB921 molecule, showing the asymmetric fit of the drug in the
groove. The drug is seen to be further away from the edges of the base pairs in the groove
on the right-hand side of the figure. Contours have been drawn at the 1.0 σ level.
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Figure 2.10B Schematic showing the hydrogen bonding distances involving the DB921
molecule, the d(CGCGAATTCGCG)2 structure, and associated water molecules. Twenty
of twenty-four bases are shown. The circled water molecule in (A) and (B) is the key
bound water which forms H-bonds with both DB921 and DNA.
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of DB921 is much greater than the corresponding radius of the DNA minor groove. The
two phenyl rings of DB921 are twisted with a dihedral angle of 28º. The amidinium
groups are also twisted out of plane, by 32º and 43º, respectively for the phenyl and
benzimidazole amidine linkages. The binding affinity and specificity involves both direct
H-bonds and water-mediated H-bonds. The amidinium group at the benzimidazole end is
hydrogen-bonded to O2 of thymine 8 (3.0 Å), and is near O4’ of cytosine 9 on the same
strand (2.9 Å). The inner-facing nitrogen atom of the benzimidazole ring forms a pair of
bifurcated hydrogen bonds with the O2 atoms of thymine 7 (2.9 Å) and thymine 19 (2.6
Å). The amidinium group at the other end of the molecule does not directly contact the
DNA. Instead, it forms a hydrogen bond (3.3 Å) to a water molecule that is part of a
network in the minor groove in this region (Figure 2.10), and which hydrogen bonds to
N3 of adenine 5 (2.9 Å). This water molecule is performing a key bridging role,
hydrogen-bonding to the base pairs at the end of the binding site as well as to DB921.
There are also two short C-H...N/O stabilizing interactions from the inner-facing edge of
the central phenyl ring to N3 of adenine 6 (3.1 Å) and to O2 of thymine 20 (2.8 Å). Thus
DB921 covers 4 of the 5 base pairs of the binding site with strong interactions by virtue
of 4 strong hydrogen bonds that arise from just the amidine-benzimidazole group and
water-mediated hydrogen bonds.
Molecular Structural Comparisons and Models
Geometry optimized models for DB921 and DB911 were compared to DB921
from the crystal structure (Figure 2.11). Without the constraints of DNA minor groove
binding, both molecules have a significant twist at the phenyl-phenyl bond of ca. 50º. In
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Figure 2.11 The bottom structure is the equilibrium geometry of DB911 calculated by
the Hartree-Fock approximation at the 321G* level and the middle structure is the
equilibrium geometry of DB921 calculated in the same way. The top structure is DB921
as in the crystal complex. Tube models are shown at right with space filling electrostatic
potential molecular surfaces on the left. The crystal structure of DB921 was frozen in the
calculations for comparison to the unconstrained low energy conformations of DB921
and DB911. A red arc is drawn on the DB911 tube structure (bottom) from amidine
carbon to amidine carbon. The same arc is shown superimposed on the DB921 calculated
structure (center).
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the crystal structure, this is reduced to < 28º. In the calculated structures of both DB921
and DB911, the amidine to aromatic ring dihedral angles are 40 ± 1º. The benzimidazoleamidine angle in the crystal structure is similar, 43°, while the phenyl-amidine angle is
reduced to 32°. The benzimidazole-phenyl angle in both the calculated and crystal
structures of DB921 is 0-1°. These results indicate that the amidine-benzimidazolephenyl end of DB921 undergoes only small structural changes upon formation of the
AATT minor groove complex, while the amidine-phenyl-phenyl end undergoes
considerable flattening.
The dramatic difference in molecular curvature between the isomers DB911 and
DB921, which is described above, can also be seen from the comparisons in Figure 2.11.
To illustrate the difference, an arc from amidine carbon to amidine carbon has been
overlaid on DB911 (Figure 2.11). The same arc on DB921 illustrates the lack of
appropriate curvature and the requirement that such compounds have for a water
interaction to forming tight interactions with bases at the floor of the DNA minor groove.
The electrostatic potential molecular surfaces of the structures are similar (Figure 2.11).
The inner face of the molecules with the benzimidazole NH group, which abuts the floor
of the minor groove, has significant positive character. The opposite face with the
unprotonated benzimidazole N, which faces the solvent, is relatively more negatively
charged. This is an advantage for both DB921 and DB911 in both formation of H-bonds
and electrostatic interactions with the DNA minor groove.
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Conclusions and Biological Relevance
We show here that both DB921 and DB911 bind preferably to the minor groove
in A·T DNA sequences of ≥ 4 base pairs. This is expected for the structure of DB911,
which is similar to those of other minor groove binding diamidines (Figure 2.1). The
strong binding of DB921, however, is unexpected based on its lack of appropriate radius
of curvature. The dogma from analysis of DNA structure has suggested that compounds
outside of a narrow curvature range should not be effective minor groove binding agents.
It is, then, particularly surprising to find that DB921 not only binds in the minor groove
but has an unusually high binding constant (Table 2.1).
For therapeutic development, it is essential to design compounds that target A·T
sequences in different but effective methods. DB921 represents a new paradigm that does
not fit the classical model of minor groove interactions. An induced fit molecular
structural change in DB921 reduces the twist of the biphenyl group to complement the
minor groove, and places the functional groups in position to interact with DNA bases at
the floor of the groove. This, of course, does not correct the lack of curvature of the
compound for minor groove binding. This deficiency is solved by incorporating a water
molecule into the complex, and the phenyl amidine group contacts the bases at the floor
of the groove through indirect contacts involving a bound water. The DB921-water pair
forms a curved noncovalent minor-groove binding module that matches the shape of the
groove.
The thermodynamic analysis of DB921 and DB911 binding to an AATT DNA
sequence shows that the stronger binding of DB921 is due to a more favorable binding
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enthalpy compared to DB911 even though it actually has a slightly less favorable entropy.
Previous studies with benzimidazole derivatives have indicated that compounds with
even slightly greater curvature than the DNA minor groove could rapidly lose binding
energy, and the structural models shown above suggest that this may be the case with
DB911. DB921, on the other hand, has an overlay small curvature for the minor groove
but the match is improved by induced-fit conformational changes and a bound water
molecule that provides a flexible way of linking the phenyl amidine group of DB921 to
the floor of the minor groove. This provides a number of additional strong DB921
interactions with DNA that are not possible with DB911. The interactions improve the
DB921 enthalpy but decrease the entropy as predicted for incorporation of a bound water
(28-30). This result, along with a previous analysis of a linear diamidine that binds
strongly in the minor groove (16), clearly suggests that traditional views of the compound
curvature required for minor groove complex formation must be reevaluated.
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Chapter 3
Evaluation of Structure-Affinity Relationship of Linear Biphenyl
Diamidine

Introduction
The DNA minor groove is one of the most successful and attractive targets for
drug design and development (1-5). Aromatic cationic diamidines binding in the minor
groove of DNA present successful and effective classes of anti-prozotoal agents (2, 3, 5).
Pentamidine is the first diamidine compound that has been used in the clinical treatment
for human African trypanosomiasis (HAT). But pentamidine has its limitations due to
side-effects and lack of oral bioavailability (5). Furamidine, DB75, is a new exciting
diamidine that exhibits excellent activities against a broad spectrum of protozoa diseases
(5-8). Its orally active prodrug DB289, the diamidoxime derivative of DB75, is currently
in Phase III clinical trials against human African trypanomiasis (HAT) and Phase II
clinical trial against malaria (9). All these biologically active diamidines have shown
strong binding preferences and high binding affinities to AT-rich sequences in the DNA
minor groove (2, 10, 11). The anti-protozoal activities of these cationic diamidines have
been hypothesized to be related to inhibition of the function of DNA-targeted
transcription enzymes, such as topoisomerases II, by interacting with DNA (12, 13).
Evidences from fluorescence microscopy studies suggest that the unique AT-rich
minicircles of mitochondrial kinetoplast DNA could be the primary targets in
trypanosome for diamidines (14).
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To gain great binding affinity to the DNA minor groove, the ligand curvature has
been considered as one of the important factors along with hydrogen-bonding and
hydrophobic interactions (15-17). The crescent shapes of ligands match the curvature of
the minor groove to yield full contact with the floor and the wall of the minor groove so
that van der Waals interaction can make significant contribution to the binding interaction
(18). Netropsin, pentamidine and furamidine (DB75) are typical examples that possess
this curved structural characteristic. These compounds all fit snugly in the minor groove
and have excellent binding affinities and specificities. On the other hand, compounds
with too linear or too curved shapes exhibit low affinity and specificity due to loss of
enough contact in the groove. Butamidine is a relative linear compound that has low
affinity to AT sequences (17), whereas DB359, a meta-meta substituted amidine isomer
of furamidine DB75, is a sample with too curved shape with reduced affinity (19).
Although the compound curvature has clear significance for strong minor groove
interactions, some recent observations have suggested that the traditional view of the
shape dependence of binding affinity might need to be reevaluated. A linear diamidine
compound, CPG 40215A, which doesn’t possess the classical curved shape, was found to
bind tightly to AT sequences (20, 21). In Chapter 2, we reported that another linear
diamidine, DB921, a linear biphenyl-benzimidazole diamidine with a central parasubstituted phenyl, was found to have significantly stronger binding affinity than its
curved isomer DB911 although DB921 obviously doesn’t match the shape of the minor
groove. These new observations raise some questions about what structural characteristic
causes these linear diamidines to have such great binding affinities. The first insight of
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the structural feature was revealed by the X-ray crystal structures of complexes of
CGP/DNA and DB921/DNA. Both crystal structures show that a bound water plays a
significant role for complex formation. A key bound water forms hydrogen bonds with
both amidine groups of these ligands and the AT base-pairs of the DNA in the minor
groove. The water-mediated compound-water system completes the curvature for these
linear compounds for strong interactions with DNA (22).
Linear CGP 40215A has demonstrated great biological activity against
Trypanosoma brucei rhodesiense (23, 24), whereas linear DB921 has shown unusual
strong binding affinity with excellent activity and selectivity against Plasmodium
falciparum with an IC50 of 0.5 nM in vitro (9). These significant linear aromatic cationic
diamidines with great binding affinity and specificity may represent a promising nonclassical group of DNA-targeted anti-protozoal agents. In part efforts to optimize
compounds in case of drug resistance as well as to develop new compounds with
improved or enhanced biological activity, structure-affinity relationships based on a
series of aromatic diamidine analogues (Figure 3.1) of DB921 have been obtained. The
apparently subtle structural variations might introduce a change of binding affinity and
the selectivity towards different receptors and thus give rise to new biological and
pharmacological activities. The goal of structure-affinity relationship (SAR) studies (2528) is to completely understand the structural features and identify the functional groups
that are vital for the unusual strong binding for the linear compounds. Such information
eventually will provide valuable direction for new non-classical drug design.
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The series of linear analogues of DB921 was obtained by altering chemical
groups, introducing new substituents or changing substituent position. The varied groups
of DB921 were divided into four parts for convenience as shown in Figure 3.1A: (I)
changing the group I position from para to meta-substituted position; (II)varying the
group II with pyridine or introducing new substituent; (III) modifying the central group
III; (IV) replacing the group IV. Curved analogues of DB921 were also investigated for
comparison (Figure 3.1B). The effects of structural modification on binding affinity and
sequence preference were studied using thermal melting (Tm) and quantitative surface
plasmon resonance (SPR) techniques. Molecular docking was used to help visualize the
binding interactions. The results reported in this chapter reveal that the linear diamidine
compounds have common structural features responsible for their significant binding
affinities.
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Materials and Methods
Materials
All DB compounds were synthesized by Dr. David W. Boykin’s group at Georgia
State University and characterized using NMR and mass spectroscopy. Double-stranded
poly(dA)·poly(dT) DNA polymer from Pharmacia (Uppsala, Sweden) and
d(CGAATTCGTCTCCGAATTCG) AATT hairpin from Midland Certified Reagent Co.
(Midland, TX) were used for thermal melting (Tm) experiments. The 5’-biotind(CGAATTCGTCTCCGAATTCG) (AATT hairpin) and 5’-biotind(CGCGCGCGTTTTCGCGCGCG) (GC hairpin) from Midland were utilized for
surface plasmon resonance (SPR) experiments. MES00 buffer used for Tm experiments
contained 0.01 M [2-(N-morpholino) ethanesulfonic acid] (MES) and 0.001M EDTA
with an adjusted pH of 6.25. MES10 buffer contained the above components plus 0.1M
NaCl. MES10 buffer used for SPR studies was added 0.005% (v/v) BIA certified
surfactant P-20 to minimize the nonspecific absorption to the autosampler tube and the
IFC channels.
Thermal Melting (Tm)
Thermal melting experiments were conducted using a Cary 300
spectrophotometer. Tm experiments of DNA in the absence and presence of DB
compounds were carried out at a wavelength of 260 nm as a function of temperature. The
temperature was monitored by a temperature probe inserted into deionized water in a
reference curvette and a rate of 0.5 ºC/min was applied. For Tm experiments with
complexes, a ratio of 0.3 compound per base was used for poly(dA)·poly(dT) while a
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ratio of one compound per hairpin was used for AATT DNA hairpin. DNA without
compound was used as a control. The thermal melting temperature (Tm) was determined
by plotting the first derivative of absorbance with respect to temperature (dA260/dT)
versus temperature, and Tm is the temperature responded to the maximum in the plot. The
melting temperature increase (∆Tm) of the complex can be obtained by subtracting the
melting temperature of free DNA from that of complex.
Surface Plasmon Resonance (SPR)
SPR experiments were performed using a BIAcore 3000 instrument. The 5’Biotin labeled DNA hairpins were immobilized on four-cell BIAcore SA sensor chips via
non-covalently capture of biotin by streptavidin linked on a dextran layer on a gold
surface. After activation by 1 M NaCl /50 mM NaOH followed by washing with buffer,
DNA at concentration of 25 nM was manually injected at a flow rate of 1 µL / min to the
flow cell until the desired amount (RU) was achieved. Three flow cells were immobilized
with DNA hairpins and one flow cell was left blank as a reference. The compounds in
different diluted concentrations in degassed and filtered MES10 buffer with 0.005% BIA
certified surfactant P-20 were injected over the immobilized DNA surface to study
binding interactions. The glycine (10 mM, pH 2.5) solution was used as a regeneration
buffer when needed. For steady-state binding studies, the RU values in steady-state
regions at each concentration were averaged over a 60-second time zone and converted to
r (moles of compound bound per mole of DNA hairpin) as previously described (29). The
binding affinities were determined by the best fitting plot of r versus free compound
concentration with a single site binding model (KA2 = 0) or a two-site binding model
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r = (KA1 * Cfree + 2* KA1 * KA2 * Cfree2) / (1 + KA1 * Cfree + KA1 * KA2 * Cfree2)
where KA1 and KA2 are the macroscopic equilibrium binding constants; Cfree is the free
compound concentration at equilibrium and is actually the compound concentration in the
flow solution herein.
Molecular Modeling
Visual docking of DB921 analogues to the AATT binding site of DNA duplex
d(CGCGAATTCGCG)2 were carried out using Sybyl software from Tripos, Inc. (St.
Louis, MO). DB921 was removed from the crystal structure of DB921/DNA complex
and modified to its analogues. The analogues were then docked into the binding site by
overlaying the structures with original crystallized DB921 structure and visually
monitoring the distances between several points consisting of the major parts of ligand
and related points on DNA duplex until the best matching with those from DB921 were
achieved. The coordinates of DNA were fixed as in the crystal structure of DB921/DNA
complex during docking. After visual docking, the distances between potential hydrogen
bonding donors and acceptors in the binding site were measured.
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Results
Thermal Melting Experiments
Thermal melting experiments were conducted to rank the relative binding
strengths of the compounds in Figure 3.1. The difference of melting temperatures (∆Tm)
of DNA at a wavelength of 260 nm in the absence and presence of ligand is the parameter
used to evaluate the stability of the complexes. Thermal melting experiments with
poly(dA)·poly(dT) were utilized as one part of rapid screening of AT-preferential minor
groove binders, whereas thermal melting experiments with short AT DNA oligomer with
a single AATT binding site were carried out for further evaluation. In Chapter 2, we
reported that the binding of DB921 is so strong that the complex with poly(dA)·poly(dT)
was not unfolded up to 95 ºC (∆Tm >28 ºC). Also, DB921 shows higher ∆Tm values (26.0
ºC) than its curved isomer DB911 (19.8 ºC) with short AATT DNA oligomer. Herein,
Figure 3.2 shows the typical thermal melting experimental profiles of DB921 analogues
with poly(dA)·poly(dT) DNA polymer, and Figure 3.3 illustrates results for a pair of
isomers among DB921 analogues with the AATT DNA oligomer. The complete ∆Tm
results are summarized in Table 3.1.
(I) Changing group I position. The new diamidine DB1055, which is derived
from altering the group I, amidine group, from the para to meta position, exhibits very
high binding strength. Its melting transition was also not observed up to 95 ºC with
poly(dA)·poly(dT) as shown in Figure 3.2, and it has a ∆Tm value of 26 ºC with AATT
DNA oligomer as high as with DB921.
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Figure 3.2 Thermal melting profiles of poly(dA)·poly(dT) without (black) and with
DB1055 (red), DB1236 (blue) and DB1111 (green) in MES10 buffer.
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Figure 3.3 Tm curves for AATT hairpin with DB1175 and DB1177. Top: Thermal
melting profiles of AATT hairpin without (black) and with DB1175 (red) and DB1177
(blue) in MES00 buffer. Bottom: The plot of their first derivatives of absorbance with
respect to temperature as a function of temperature for DNA.
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Table 3.1 ∆Tm values of the analogues of DB921 with AT DNAs
Compound

a

Group modified

∆Tm ( ºC ) a

∆Tm ( ºC ) b

(poly(dA)·poly(dT))

(AATT)

DB921

NA

>28

26.0

DB1055

I

>28

26.0

DB922

II

~ 27 - 28

24.0

DB1250

II

>28

24.0

DB942

II

~ 27 - 28

24.3

DB985

II

~ 27 - 28

23.2

DB988

II

25.5

20.5

DB1236

III

~ 27 - 28

22.4

DB1302

IV

17.8

14.0

DB1100

IV

12.9

9.6

DB1177

IV

>28

22.2

DB1111

IV

19.1

DB911*

NA

25.3

19.8

DB853*

II

24.4

18.8

DB1114*

IV

16.1

10.9

DB1175*

IV

20.9

15.1

A molar ratio of 0.3 compound per DNA base was used for experiments with
poly(dA)·poly(dT) in MES10 buffer
b
A molar ratio of one compound per DNA hairpin was used for experiments with AATT
DNA in MES00 buffer.
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(II) Varying group II. Modifications of group II, a phenyl group in DB921,
involved replacing the phenyl with pyridine groups (DB922 and DB1250) or introducing
fluorine (DB942), hydroxyl (DB985) or methyl groups (DB988). These structural
changes mostly have no significant effects on Tm with both poly(dA)·poly(dT) and short
AATT DNA oligomer compared to DB921. The only exception is the derivative DB988
with a methyl substituent near to the junction between the two phenyl rings among this
set of structural variations. The relative lower ∆Tm values of DB988 are presumably due
to the increase in the torsion angle of DB988 caused by introduction of methyl group. For
curved DB921 analogues in this set, DB853 with pyridine substitution is a structural
isomer of DB922. In like manner, linear DB922 binds more strongly to AT sequences in
DNA than its curved isomer DB853 as with DB921 and DB911 (Figure 3.1).
(III) Modifying central group III. DB1236 has a fluorine substituent on the central
phenyl ring, but this modification also does not notably influence the binding strength as
indicated by ∆Tm values in comparison with DB921.
(IV) Replacing group IV. The group IV, benzimidazole group of DB921, was
altered by introducing a methyl group on nitrogen (DB1302) or substituting with
benzoxazole (DB1100), naphthalene (DB1177) or phenyl (DB1111) group. In contrast to
the above three sets of structural variations, changing the benzimidazole group has
significant effects on the binding affinity. The binding affinities are dramatically reduced
when introducing a methyl group or substituting with benzoxazole or phenyl group as
expected due to loss of hydrogen bonding interaction. ∆Tm values are decreased by more
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than 10 °C with both poly(dA)·poly(dT) and AATT DNA oligomer. This indicates that
the group IV benzimidazole is the most sensitive group for linear diamidines. One
compound DB1177 exhibits extremely high stability with poly(dA)·poly(dT) with a ∆Tm
> 28 °C. It is a somewhat surprising because the substitution of benzimidazole group with
naphthalene caused a loss of the hydrogen donor. However, a reasonable high ∆Tm of
22.2 °C with AATT DNA oligomer was observed and this is in good agreement with
SPR results as reported later. It should be noted that Tm with poly(dA)·poly(dT) is only a
rapid and effective screening approach, and detailed quantitative binding affinity has to
be measured with other methods, such as SPR. Again, the linear analogue (DB1177)
stabilizes AT DNA much more that its curved isomer (DB1175). Additionally, the
benzoxazole analogue DB1100 has exceptionally weak binding to AT DNA along with
its curved analogue DB1114.
Surface Plasmon Resonance Experiments
SPR experiments were used to quantitatively explore the effects of structural
change on the binding affinity. The 5’-biotin-CGAATTCGTCTCCGAATTCG (AATT
hairpin) were immobilized on Biacore SA (streptavidin coated) sensor chips for SPR
binding studies. To probe the binding sequence specificity, the 5’-biotinCGCGCGCGTTTTCGCGCGCG (GC hairpin) were also immobilized on the sensor
chips for comparison. Typical examples of SPR sensorgrams for binding interactions
between aromatic diamidine analogues and DNAs are illustrated in Figure 3.4 and Figure
3.5. The binding data were fitted with a two-site
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Figure 3.4 SPR sensorgrams for binding of DB985 to AATT hairpin (top) and GC
hairpin (bottom), respectively, in MES10 buffer at a flow rate of 20 µL/min. The
concentration ranges are from 0.001 µM to 0.1 µM for both sensergrams.
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Figure 3.5 SPR sensorgrams for binding of DB1302 to AATT hairpin (top) and GC
hairpin (bottom), respectively, in MES10 buffer at a flow rate of 30 µL/min. The
concentration ranges are from 0.02 µM to 1.0 µM for both sensorgrams.
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model or one-site model (see Materials and Methods) to determine binding affinities (KA).
As discussed in Chapter 2, DB921 has a l:1 stoichiometry with AATT DNA. Most
analogues in Figure 3.1 also have a 1:1 stoichiometry (KA1 >100 KA2). DB1111, DB1114
and DB1175 probably have non-specific binding at higher concentration, which is
reflected by relative higher KA2 values. The complete SPR binding profiles are
summarized in Table 3.2 and Figure 3.6. The SPR results are in very good agreement
with Tm results.
(I) Changing the group I position. Just as with Tm results for changing the amidine
group from para to meta-substituted position, SPR results show that DB1055 binds very
strongly to AATT DNA with AT sequence preference.
(II) Varying the group II. Most analogues generated from altering the group II, phenyl,
still have strong binding to AT DNA with binding constants (KA) at around 1×108 M-1.
DB988 has a relatively lower KA value which is consistent with Tm results. SPR results
quantitatively show that the linear compounds have stronger binding to AATT DNA than
their curved isomers (compare DB921 to DB911 and DB922 to DB853) as illustrated in
Figure 3.7. The pyridine-substituted DB922 also has almost 10 times stronger binding
than its curved isomer DB853.
(III) Modifying the central group III. SPR binding studies show that DB1236 still has
tight binding to AATT DNA, indicating that this modification on central phenyl group
has little effect on binding affinity.
(IV) Replacing the group IV. SPR binding studies, as with Tm results, clearly show
that group IV is a key DNA interaction component of DB921. Structural variations of the
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Figure 3.6 Binding curves of near-linear aromatic analogues derived by variations of
group II (green), group III (red), group IV(blue) of DB921 (black) with AATT DNA in
MES10 buffer at 25 °C.
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Table 3.2 Binding affinities of the analogues of DB921 with AATT DNAa
Compound

Group modified

KA (M-1) b

KA1 (M-1) c

KA2 (M-1) c

DB921

NA

7.0 ×108

DB1055

I

6.2 ×108

DB922

II

1.2 ×108

DB1250

II

9.8 ×107

DB942

II

2.0 ×108

DB985

II

1.8 ×108

DB988

II

7.0 × 107

DB1236

III

1.2 ×108

DB1302

IV

5.3 ×106

DB1100

IV

< 106

DB1177

IV

8.5 ×107

DB1111

IV

5.4 ×106

6.6 ×106

1.3 ×105

DB911*

NA

5.1 ×107

DB853*

II

2.0 ×107

DB1114*

IV

1.4 ×106

1.0 ×106

1.3 ×105

DB1175*

IV

6.9 ×106

8.2 ×106

2.9 ×105

a

All SPR experiments were conducted in MES10 buffer at 25 °C.

b

Obtained from steady-state one-site binding model.

c

Obtained from steady-state two-site binding model.

*Curved analogues of DB921
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Figure 3.7 Comparison of binding curves of near-linear-shaped aromatic diamidines
(solid dots) with their curved isomers (solid squares) to AATT DNA. Top: DB921
(near-linear shape) versus DB911 (curved shape). Bottom: DB922 (near-linear shape)
versus DB853 (curved shape).
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benzimidazole group have significant influence on the binding affinity. Introducing a
methyl group on nitrogen on the benzimidazole ring (DB1302) or substituting phenyl
group (DB1111) dramatically reduces the binding affinity more than 100 times. In good
consistence with Tm results, replacing benzimidazole with a benzoxazole group (DB1100)
reduces the binding to AATT DNA. DB1100 loses the binding specificity to AATT DNA
and the binding is too weak to measure under our experimental conditions. On the other
hand, replacing with naphthalene group (DB1177) only causes a small decrease of
binding affinity. It is probably related to the change of curvature and better hydrophobic
interaction as discussed later. Moreover, DB1177 still has stronger binding to AATT
DNA than its curved isomer DB1175. In addition, DB1111 and curved analogues
DB1114 and DB1175 have KA1 values which are not more than 100 times higher than
KA2 values, suggesting that there are some non-specific binding interactions for these
weaker AT sequence binders.
Molecular Modeling
Linear DB921 has been crystallized with DNA duplex d(CGCGAATTCGCG)2 as
discussed in Chapter 2. The X-ray crystal structure of the DB921/DNA complex reveals
that DB921 binds in the DNA minor groove at the central AATT site (Figure 3.8). Direct
hydrogen bonds between the benzimidazole and benzimidazole-amidine groups of
DB921 and AT basepairs are involved. A key bound water forms hydrogen bonds with
phenyl-side amidine group of DB921 and N3 of adenine 5 of DNA at the opposite end of
DB921. The water-mediated H-bonding plays a vital role for compensating the curvature
of the linear DB921 molecular system.
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2.9Å
3.3Å

Figure 3.8 Crystal structure of DB921 bound to d(CGCGAATTCGCG)2 duplex from a
side view (left) and a top view (right) (22). The red sphere is the key bound water.
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Molecular modeling was used to aid in understanding the binding interactions of
DB921 analogues with DNA since there are at present no crystal structures for these
analogues. While docking, the DB921 structure was modified without structural
optimization to keep its best orientation in the DNA complex. The modified analogues
then were overlapped into binding site by visual distance docking until best overlap with
the original crystallized bound DB921 at unchanged structural parts was obtained, as
described in the Method section.
The visual distance docking of DB921 analogues show that DB922, DB1205,
DB942 and DB985 are still in hydrogen bonding distance regions with the bound water
for DB921. An example of a computer modeling structure of DB922 and DNA is shown
in Figure 3.9. The distance between the terminal phenyl amidine group of DB922 and the
bound water is estimated as 3.32 Å. The modeling structures were also overlaid with
original DB921 crystal structure for comparison. The results suggest that the watermediated interaction probably also has critical roles for the strong binding interactions of
these linear compounds as with DB921. On the other hand, DB1055 with a metasubstituted amidine group presumably forms a directed hydrogen bond (2.72 Å) to N3 of
adenine 5 at the binding site as illustrated in Figure 3.10. This may explain that strong
binding of DB1055 is possibly due to direct hydrogen-bonding interactions between the
terminal phenyl amidine group of DB1055 and N3 of adenine of DNA. This interaction
could take the place of the indirect water-mediated hydrogen-bonding interaction for
DB921 occurring in the same coordinate space at binding site.
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Figure 3.9 Computer modeling structure of DB922 bound to d(CGCGAATTCGCG)2
duplex using visual distance docking (left) and overlaying DB922 (shown as purple) with
DB921 (shown as yellow) structures at AATT binding site (right).
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Figure 3.10 Computer modeling structure of DB1055 bound to d(CGCGAATTCGCG)2
duplex using visual distance docking (left) and overlaying DB1055 (blue) with DB921
(yellow) at AATT binding site (right).
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Discussion
The structure-affinity relationships (SAR) have been studied on a series of
analogues of DB921 to determine how structural variations affect the binding affinity.
The thermal melting and quantitative SPR results are in very good agreement. Both
methods reveal the vital groups for binding to AT sequence DNA.
Introduction of a methyl group on nitrogen (DB1302) on the benzimidazole ring
of DB921 eliminates the hydrogen donor and important hydrogen-bonding interactions
with O2 atoms of thymine acceptors on DNA in the minor groove. Conversion of the
benzimidazole group to a phenyl group (DB1111) gives a completely straight linear
shape and loses a hydrogen donor group. As a result, the binding affinities are
dramatically reduced by more than 100 times compared to DB921. Furthermore,
changing the benzimidazole group to a benzoxazole group (DB1100) significantly
reduces the binding to AATT DNA. This is caused by removal of hydrogen bonding
donor but other factors must be involved to explain the extreme loss in binding, such as
unfavorable hydrophobic interaction due to introducing polar oxygen atom to the
aromatic ring. Interestingly, substitution with naphthalene group (DB1177) only reduces
the binding affinity by a small magnitude. As shown in Figure 3.6, the binding interaction
of DB1177 is strong in contrast to significant reduction of binding affinity for most group
IV changes. The small effect of naphthalene substitution on binding may be partially
associated with the change of curvature. Unlike the little shape change for DB1302 and
DB1100, DB1177 has a relative more curved shape than DB921 as shown in Figure 3.11.
The naphthalene group may also contribute a more favorable hydrophobic
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Figure 3.11 Comparison of molecular curvature of DB 921 with its analogues. The
structures were projected onto a planar surface after energy minimization to assist in
visualization of difference. Top: DB1302 (red) superimposed on DB921 (yellow).
Bottom: DB1177 (green) superimposed on DB921 (yellow).
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term to the binding interaction than the benzimidazole group. This curved shape may
compensate the loss of hydrogen donor by gaining more contact with the minor groove.
The more curved analogue, DB1175, has weaker binding than DB1177, which may be
because of too curved shape resulting in less contact with walls of the minor groove.
Conversion of the amidine from para to meta-substituted position on phenyl ring
(DB1055) does not reduce the binding affinity relative to DB921. The computer
modeling structure of DB1055 bound to AATT duplex suggests that the phenyl amidine
group may form a direct hydrogen bond with N3 of adenine instead of through water
bridging. Figure 3.12 shows the molecular curvature of DB1055 after energy
minimization compared to DB921. As can be seen, the conversion of amidine position
changes the molecular curve. In the case of DB1055, it has better curvature to fit the
minor groove and obtain the direct molecular interaction for the phenyl amidine group.
On the other hand, it confirms that bound water can be used to improve the molecular
curvature and facilitate the binding interaction with DNA for linear diamidine
compounds that lack direct contact with minor groove on one end. Clearly, water can be a
flexible docking component for strong binding of compounds, such as DB921, which
have an appropriate shape.
Modification of amidine phenyl group has little influence on binding affinity
except DB988. This reduction may be related to the larger torsion angle for DB988. The
space filled structures for DB921 and DB988 after equilibrium geometry calculation with
Hartree-Fock approximation at 321-G* level are compared in Figure 3.13. DB988 has a
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A

B

Figure 3.12 Comparison of molecular curvature of DB 921 (A) and DB1055 (B). The red
sphere in (A) is the key bound water. The structures were projected onto a planar surface
after energy minimization to assist in visualization of difference.
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A

B

Figure 3.13 Space filling models for equilibrium geometry structures of DB 921 (A) and
DB988 (B) calculated by Hartree-Fock approximation at the 321G* level.
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more significant twist than DB921 at the phenyl-phenyl bond due to introduction of a
methyl group on the phenyl ring. The dihedral angle of two phenyl rings is ca. 50 ° for
DB921 and is ca. 85 ° for DB988. The crystal structure of DB921/DNA reveals that this
dihedral angle of DB921 is reduce to < 28 ° to adapt to the groove when DB921 fits into
the minor groove. It, therefore, is reasonable to consider that the lower binding affinity
of DB988 arises from cost of more energy to reduce the larger torsion when its binds to
DNA.
In conclusion, the results of structure-affinity relationship studies offer very
important information for identification of the key function groups responsible for the
strong binding of the linear compound. As presented in Figure 3.14, there are at least
three significant structural characters for linear diamidine compounds to gain great
binding affinity: (i) a bound water forming hydrogen bonds with both ligand and DNA
needs to be involved to compound structural system to compensate the molecular
curvature for matching the minor groove of DNA; (ii) benzimidazole group is the
sensitive and key group to form essential hydrogen-bonding interactions with AT
basepairs of DNA; (iii) one amidine group has to be anchored in the minor groove
through forming hydrogen bonds with AT basepairs in the minor groove for tight
interaction. These structure binding affinity relationship studies may provide some
patterns for designing new non-classical sequence-specific groove DNA-binding agents.
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Figure 3.14 Scheme of molecular recognition of DB921 to DNA.
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Chapter 4
Energetics of Strong Binding of Near-linear Biphenyl Diamidines in the
DNA Minor Groove

Introduction
Investigation of nucleic acid-ligand interactions is an important area of
fundamental interest (1-3). Specific interactions between nucleic acids and proteins in
vivo play vital roles in gene transcription, gene replication, and other important biological
processes. The specific binding of small molecules to nucleic acid is a potent approach to
inhibit gene transcription and regulate gene expression (4, 5). Numerous DNA-targeted
agents have been designed, synthesized, and studied for drug development. It has been
found that the biological activities of many antibiotic, anti-viral, antiparasitic, and
anticancer drugs are related to reversible interactions with DNA (6-9). Intercalation and
minor groove binding are the most common types for reversible binding interaction (7),
and binding interactions of small molecules with the minor groove of DNA are of
particular interest. For a complete understanding of the molecular interactions between
drugs and DNA, it is necessary and essential to gain detailed thermodynamics insights
into the process (10-16). Thermodynamics provides the critical information about the
energetic driving force for complex formation. The integration of thermodynamic with
structural and kinetic studies offers important information for the rational design and
development of DNA-targeted compounds that have new or enhanced biological activity.
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Aromatic diamidine compounds have shown excellent biological activities against
a broad spectrum of protozoal diseases (6, 8). An oral prodrug of furamidine (DB75) is
currently in Clinical Phase III trials against human African trypanosomiasis (HAT) (17).
A modified derivative, DB293, was reported to form a stacked dimer that can recognize
mixed base-pair DNA sequences (18, 19). A linear diamidine, CGP, which exhibits
excellent activity against trypanosoma brucei rhodesiense, was found to bind to AT DNA
strongly (20, 21). Recently, we reported that another linear diamidine compound, DB921,
binds strongly to AT DNA and the binding constant is even higher than its curved isomer
DB911 (Figure 4.1). The crystal structure of the DB921/DNA complex reveals that a
bound water provides a significant contribution for DB921/DNA complex formation (22).
Tight binding of both these two linear diamidines, CGP and DB921, involves a bound
water that forms hydrogen bonds with an amidine group of the ligand and the AT base
pair groups in the minor groove floor. The bound water completes the curvature of the
ligand and contributes to the strong interaction with the minor groove. It is important to
understand what drives this linear compound, DB921, to bind more strongly than its
curved isomer DB911 that has a classical crescent shape, and what the contribution for
the bound water is. Therefore, it is critical to investigate the thermodynamics of the
binding interaction in detail. Dissecting and quantifying the contributions from different
energetic components will elucidate the dominant energetic factors that govern the
binding affinity.
To help better understand the basis of the tight binding of the linear diamidine
DB921, another isomer of DB921, DB1055 (Figure 4.1), with a meta-substituted amidine
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was designed and synthesized. It was previously reported that DB921 and DB1055 have
similar strong ∆Tm values with AT DNA polymer and oligomer sequences but they
demonstrate different biological activities (17). DB921 has excellent activity and
selectivity for plasmodium falciparum (P. f.) with an IC50 of 0.5 nM while DB1055 has
good activity and selectivity to trypanosoma brucei rhodesiense (T. b .r.). It is important
to understand the difference in energy contributions to the binding interactions of these
structural isomers.
To acquire the complete thermodynamic profiles (binding free energy, enthalpy
change, entropy change, and heat capacity change) for the binding interactions between
three cationic benzimidazole-biphenyl-diamidine isomers, linear DB921, curved DB911,
and near-linear DB1055, and DNA, isothermal titration calorimetry (ITC) (15, 16, 23)
and surface plasmon resonance (SPR) techniques (24-26) were utilized. Temperature and
salt dependence of binding affinity using SPR and temperature dependence of enthalpy
change using ITC were investigated. The detailed thermodynamic studies and evaluation
of energetic contributions from each factor provide a wealth of information about binding
interactions and allow us to explain and understand the important energetic forces that
drive the difference in binding affinity and binding free energy between these structural
isomers.
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Materials and Methods
Materials
Biphenyl benzimidazole diamidines (DB921, DB911, DB1055) were synthesized
by Dr. David W. Boykin and co-workers. The DNA oligomers were purchased from
Midland Certified Reagent Co. (Midland, Texas) with reversed- phase HPLC purification
and mass spectrometry characterization. All experiments were conducted in MES 20
buffer containing 0.01M [2-(N-morpholino) ethanesulfonic acid] (MES), 0.2M NaCl, and
0.001M EDTA with adjusted pH of 6.25. An amount of 0.005% (v/v) BIA certificated P20 surfactant was added to MES20 buffer for biosensor SPR studies.
Biosensor-Surface Plasmon Resonance (SPR)
Biosensor-SPR experiments were carried out with a BIACORE 3000 (Biacore,
Uppsala, Sweden) instrument. 5’-Biotin labeled DNA hairpins were immobilized on a
BIAcore SA sensor chip that has streptavidin on the surface by biotin capture. Three flow
cells were immobilized with biotin-labeled DNA hairpins and one flow cell was left
blank as a reference. The compounds at different concentrations diluted with degassed
and filtered MES 20 buffer were injected over the immobilized DNA surface for selected
times followed by injection of MES20 buffer to obtain both association and dissociation
information. A glycine solution (10mM, pH 2.0) was used as a regeneration solution.
The binding constants were determined by both steady-state analysis and kinetic analysis.
For steady-state analysis, bind constant, KA, was obtained by the best fit of r versus free
compound concentration (Cfree) with equation
r = (KA*Cfree) / (1+KA*Cfree)

(1)
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where r is the moles of bound compound per mole DNA hairpin as previously described
(27). For kinetic analysis, the association rate constant (ka) and dissociation rate constant
(kd) were obtained by globally fitting the data with mass-transport-limited kinetic 1:1
binding models as previously described (22). The binding constant was determined by the
ratio of association rate constant (ka) and dissociation rate constant (kd), KA = ka/kd.
Isothermal Titration Calorimetry (ITC)
ITC experiments were conducted with a MicroCal VP-ITC (MicroCal Inc.,
Northampton, MA) isothermal titration calorimeter. ITC data were analyzed with Origin
5.0 software. The sample cell was filled with degassed AATT DNA duplex diluted in
MES 20 buffer and reference cell was filled with degassed MES20 buffer while the
compound solution was introduced into a 250 µL syringe. In a titration experiment, the
compound solution was injected into sample cell containing DNA solution at a volume of
10 µL every 300 seconds at a stirring rate of 290 RPM. The observed heat for each
injection was measured by integration of the area of power peak with respect with time.
A blank heat of dilution titration was also conducted by injecting the compound solution
into the sample cell containing only MES20 buffer under same conditions in order to
correct the interaction heat. The final binding interaction heat was determined after
subtracting the heat of blank heat dilution titration. Due to the strong binding of these
compounds and the relatively small heats of interactions, only the enthalpy change, ∆H,
could be obtained from the ITC experiment. The ∆H values were determined by
averaging the heats per mole in a range of 0.2 to 0.7 molar ratios.
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Results
Biosensor-Surface Plasmon Resonance (SPR)
The binding constants and Gibbs free energy changes (∆G) for binding
interactions between the three isomers and DNAs were determined by Biacore SPR
experiments. SPR is a powerful tool for providing insights into binding specificity,
binding affinity, and kinetics, especially for compounds with very low dissociation
constants (KD). To explore the temperature dependence of binding free energy change,
the binding studies with AATT DNA were also carried out over a range of temperatures
between 10–35 °C for each compound. Examples of SPR sensorgrams at 10 °C, 20 °C,
and 30 °C for DB921 binding to AATT DNA are illustrated in Figure 4.2. The black
solid lines are the best global kinetic fitting curves. Typical SPR spectra for DB911 and
DB1055 are shown in Figure 4.3 and Figure 4.4, respectively.
Binding Constant Comparisons
The binding constants for three structural isomers obtained by both steady-state
analysis and kinetic analysis at different temperatures are compared in Table 4.1- Table
4.3. The KA values from both analysis models are very close. The binding constants at
10°C, 15°C and 20 °C for DB921 and DB1055 were only determined by mass-transport
kinetic analysis (see method), KA = ka/kd, since the steady states were not reached at
some low concentrations. It is clear that the linear DB921 and the meta-substituted
amidine isomer DB1055 have significantly stronger binding affinities than its metasubstituted phenyl isomer DB911 at all temperatures tested by a factor of approximately
10. Both DB921 and DB1055 show very tight binding to AATT DNA with binding
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Figure 4.2. SPR sensorgrams of binding interaction between DB921 and AATT DNA at
(A)10 °C, (B)20 °C, and (C)30 °C, respectively. The concentration ranges from the
bottom curve to the top curve are 0.0006 to 0.04 µM for all sensorgrams. The black solid
curves are the best global fitting curve with mass transfer kinetic model.
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Figure 4.3 SPR sensorgrams of binding interaction between DB911 and AATT DNA at
(A)15 °C, (B)20°C, and (C)35°C, respectively. The concentration ranges from the bottom
to the top curve are (A) 0.01 to 0.10 µM; (B) 0.006 to 0.10 µM; (C) 0.006 to 0.10 µM.
The black solid curves are the best global fitting curve with mass transfer kinetic model.

106

DB1055_AATT_MES20_T20

RU
40
35
30
Resp. Diff.

25
20
15
10
5
0
-5
400

600

800

1000

1200

1400

1600

1800
s

Tim e

DB1055_AATT_MES20_T25

RU
40
35
30
Resp. Diff.

25
20
15
10
5
0
-5
-10
400

600

800

1000

1200

1400

1600

1800
s

Tim e

DB1055_AATT_MES20_T30

RU
35
30

Resp. Diff.

25
20
15
10
5
0
-5
400

600

800

1000

1200

1400

1600

1800

Tim e

s

Figure 4.4 SPR sensorgrams of binding interaction between DB1055 and AATT DNA at
(A)20 °C, (B)25 °C, and (C)35 °C, respectively. The concentration ranges from bottom
curves to the top curves are (A) 0.0006 to 0.04 µM; (B) 0.001 to 0.04 µM; (C) 0.001 to
0.04 µM. The black solid curves are the best global fitting curve with mass transfer
kinetic model.
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Table 4.1. Binding constants of DB921 to AATT DNA at different temperatures in
MES20 buffer
KA kina (1/M)

KA eq b (1/M)

MT

4.8 ×108

-

MT

MT

3.8 ×108

-

20 °C

MT

MT

3.1 ×108

-

25 °C

MT

MT

2.6 ×108

-

30 °C

MT

MT

1.4 ×108

1.3 ×108

35 °C

MT

MT

1.3 ×108

1.1 ×108

Temp.

ka (1/Ms)

10 °C

MT

15 °C

kd (1/s)

Note: MT: mass transport limitation
a

KA values were determined by KA = ka / kd

b

KA values were determined by fitting with steady–state binding model

*All experiments were performed in MES20 buffer at a flow rate of 30 µL/min.
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Table 4.2 Binding constants of DB1055 to AATT DNA at different temperatures in
MES20 buffer
KA kina (1/M)

KA eq b (1/M)

MT

3.6 ×108

-

MT

MT

3.3 ×108

-

25 °C

MT

MT

2.1 ×108

-

30 °C

MT

MT

1.6 ×108

1.3 ×108

35 °C

MT

MT

9.7 ×107

8.9 ×107

Temp.

ka (1/Ms)

15 °C

MT

20 °C

kd (1/s)

Note: MT: mass transport limitation
a

KA values were determined by KA = ka / kd

b

KA values were determined by fitting with steady–state binding model

*All experiments were performed in MES20 buffer at a flow rate of 30 µL/min.
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Table 4.3 Binding constants and kinetics of DB911 to AATT DNA at different
temperatures in MES20 buffer
Temp.

ka (1/Ms)

kd (1/s)

KA kina (1/M)

KA eq b (1/M)

15 °C

MT

MT

2.5 ×107

2.8 ×107

20 °C

1.1 ×106

0.046

2.4 ×107

2.1 ×107

25 °C

1.4 ×106

0.075

1.9 ×107

1.7 ×107

30 °C

Too fast

Too fast

1.8 ×107

1.6 ×107

35 °C

Too fast

Too fast

1.5 ×107

1.2 ×107

a

KA values were determined by KA = ka / kd

b

KA values were determined by fitting with steady–state binding model

*All experiments were performed in MES20 buffer at a flow rate of 30 µL/min.
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affinities in a range of 108- 4 ×108 M-1 over a temperature range of 10-35 °C, while
DB911 has binding affinities in the range of 107- 3 ×107 M-1 over the same temperatures.
The similarity of binding constants of DB921 and DB1055 is consistent with thermal
melting results as reported in Chapter 3.
Temperature Dependence of Binding Kinetics, Binding Affinity and Gibbs Free
Energy
It appears that the shapes of binding sensorgrams are significantly influenced by
temperature for all three isomers as shown in Figure 4.2- 4.4. Both observed association
rate and dissociation rate increase as the temperature is increased as expected (28) and it
takes longer time to reach the steady state at the lower temperatures. For DB921 and
DB1055 the binding rates were strongly dominated by mass transport effects over all
temperatures, so only KA but not ka and kd values were reliably determined under the
experimental conditions (28). For DB911, both binding kinetics and binding affinities
were obtained above 20 °C. The kinetic data determined from mass-transport and nonmass-transport models are in good agreement, suggesting the kinetics constants are not
limited by mass transport effects under these conditions. The ka value and kd value
increase from 1.1 ×106 M-1s-1 to 1.4 ×106 M-1s-1 and from 0.046 s-1 to 0.075 s-1,
respectively, when increasing temperature from 20 to 25 °C. This is consistent with the
binding sensorgram shape changes with temperature. The binding rate was governed by
mass transport effects below 20 °C, and the association and dissociation rates were too
rapid to measure by SPR at 30 °C and 35 °C.
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Although the observed association rate and dissociation rates increase with
temperature, the equilibrium binding constants (KA) change only slightly, a small
decrease, due to compensation of ka and kd change. The calculated binding free Gibbs
energies (∆G = -RTlnKA) based on SPR binding constants at different temperatures were
plotted as a function of temperature in Figure 4.8. It clearly illustrates that binding Gibbs
energy is quite insensitive to the temperature. This is typical of heterocyclic diamidine
minor groove binders (18, 27).
Sequence Specificity
To visualize the sequence specificity, the binding studies of three isomers with
GC sequence DNA (Table 4.1) have also been performed. Figure 4.5 shows the SPR
sensorgrams for binding three compounds to GC DNA at 20 °C under the same
concentrations (0.0004 – 0.1µM) and conditions as with AATT DNA. The RU responses
with GC DNA are almost zero or very weak for all three diamidine isomers. SPR results
clearly and rapidly demonstrate that the binding of these diamidines to GC DNA is much
weaker than AT sequence DNA at all temperature studied. These results confirm their
strong binding preference to AT sequences rather than GC sequences as with other
typical minor groove binders (7, 29).
Salt Dependence of Binding Affinity
DB921 is a dicationic ligand with positive charges at two amidine groups under
physiological condition. Binding affinity has been found to be salt dependent for most
cationic AT minor groove binders. Record and co-workers have derived a theoretical

112

DB921_GC_mes20_T20

RU
20

15

Resp. Diff.

10

5

0

-5
400

600

800

1000

1200

1400

1600

1800
s

Tim e

DB1055_GC_mes20_T20

RU
20

15

Resp. Diff.

10

5

0

-5
400

600

800

1000

1200

1400

1600

1800
s

Tim e

DB911_GC_mes20_T20

RU
20

15

Resp. Diff.

10

5

0

-5
400

500

600

700

800
Tim e

900

1000

1100

1200
s

Figure 4.5 SPR sensorgrams for the interactions between DB921, DB1055, DB911 and
GC sequence DNA in MES20 buffer at 20 °C. The concentration ranges for all
sensorgrams are from 0.0004 to 0.1 µM.
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formulation for addressing the correlation of the binding affinity of ligands to nucleic
acids with the salt concentration (30):
δlogK / δlog[M+]= -z φ
where K is binding constant, M+ is the monovalent cation concentration, z is the number
of ion pairs formed, which usually is the charge of small molecule, and φ is the average
fraction of monovalent cation associated per phosphate of nucleic acid.
We have reported that the two positive charged amidine groups of our lead
compound DB75 and its derivative DB293 have the full charge effects on the ion-pairing
interaction (27, 31). DB921, however, possesses a quite different shape from these
“classical” compounds and clearly does not fit the shape of minor groove. The complex
structure of DB921 and DNA shows that the benezimidazole amidine group is anchored
in the minor groove at AATT site with another amidine end off the groove floor (22). To
determine the charge effect of linear DB921, we have measured the binding constants, KA,
as a function of salt concentration using SPR. Figure 4.6 shows the binding curves of
DB921 at different concentrations. The binding strength of DB921 is strongly salt
dependent as expected. On increasing the salt concentration, the binding affinity is
reduced due to the electrostatic competition between the positive groups of the ligand and
monocations. The plot of log K of DB921 versus log Na+ is shown in Figure 4.7. The
slope, -z φ value, yielded from the best linear fitting is -1.50 ± 0.04. If using the φ value
0.88 for native B DNA polymer (30), then the calculated z value is 1.7. However, it has
been observed that φ value should be less than 0.88 for short nucleic acid oligomers (3235). The z value, therefore, is actually underestimated for the short DNA oligomer we
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Figure 4.6 Binding curves of DB921 with AATT DNA at different NaCl concentrations
at 25°C.
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Figure 4.7 Plot of logK versus log[Na+] for DB921 binding to AATT DNA at 25 °C.
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used if using φ = 0.88. It indicates that both two positive charges of DB921 exert the full
electrostatic interactions with the phosphate groups on the DNA backbone.
Isothermal Titration Calorimetry (ITC)
Isothermal titration calorimetry experiments were performed to gain a detailed
thermodynamic understanding of the driving forces and contributions for these three
structurally-related amidine isomers as well as the influence from the bound water. Due
to very high binding constants and small interaction heats, ∆H but not K values can be
obtained from ITC (36). Titrations of compound into DNA were repeated at several
temperatures in a range of 10 to 35 °C to acquire the information about heat capacity
change (∆Cp), another very important thermodynamic parameter for characterizing the
importance of water in nucleic acid complexes.
Isothermal titration calorimetry results obtained for the interactions of DB921,
DB9211 and DB1055 with d(GCGAATTCGC)2 duplex in MES20 buffer at 20 ºC are
shown in Figure 4.8, Figure 4.9 and Figure 4.10, respectively. In each figure, the top
panel is the experimental ITC titration curve and the bottom panel is a plot of integrated
heat per mole of compound versus molar ratio of compound to DNA duplex after heat
dilution corrections. As can be seen, because of the strong binding of these compounds to
DNA, the heat per mole is eventually constant below saturation of binding site. The ∆H
values were thus determined by averaging the heat per mole of compound at molar ratios
in the linear range, 0.2-0.7. The binding free energy changes (∆G) were derived from the
binding constants obtained by SPR, as described above and the T∆S values were
calculated by ∆G = ∆H-T∆S, and the thermodynamic parameters (∆G, ∆H, and T∆S) of
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Figure 4.8 ITC experimental plots of titration of 0.025 mM DB921 into 0.004 mM
d(GCGAATTCGC)2 duplex in MES20 buffer at 20 °C. Top: Raw experimental ITC
titration curve of a serial 10 µL-injection of DB921 into DNA solution every 300 seconds.
Bottom: The plot of heat per mole as a function of temperature after heat dilution
correction.
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Figure 4.9 ITC experimental plots of titration of 0.025 mM DB911 into 0.004 mM
d(GCGAATTCGC)2 duplex in MES20 buffer at 20 °C. Top: Raw experimental ITC
titration curve of a serial 10 µL-injection of DB911 into DNA solution every 300 seconds.
Bottom: The plot of heat per mole as a function of temperature after heat dilution
correction.
Note. The plots are shown in same scale as Figure 4.8 for DB921 for comparison.
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Figure 4.10 ITC experimental plots of titration of 0.025 mM DB1055 into 0.004 mM
d(GCGAATTCGC)2 duplex in MES20 buffer at 20 °C. Top: Raw experimental ITC
titration curve of a serial 10 µL-injection of DB1055 into DNA solution every 300
seconds. Bottom: The plot of heat per mole as a function of temperature after heat
dilution correction.
Note. The plots are shown in same scale as Figure 4.8 for DB921 for comparison.
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three diamidine isomers are plotted as a function of temperature in Figure 4.8. In sharp
contrast to the insensitivity of ∆G to temperature, ∆H is strongly dependent upon the
temperature (Figure 4.11). The ∆H values are more negative when increasing the
temperature. The best linear fitting of the plot of ∆H versus temperature yields the heat
capacity change, ∆Cp.
The complete thermodynamic parameters of the three DB921 analogs at 298 K
are summarized and compared with previously reported results of the parent compound
DB75 and DB293 in Table 4.4. The binding interactions of all these amidines are mainly
entropy-driven as can be seen. It is, however, very clear that the strong binding of DB921
and DB1055 arise from more favorable enthalpy changes compared to DB911 since their
entropy changes are similar. Also, it should be noted that the ∆Cp value is different for
each of the three isomers. DB921 has a more negative ∆Cp value than DB911 and
DB1055. Interestingly, although DB921 and DB1055 have very close binding affinities
or binding free energies and similar energy driven forces in terms of enthalpy change and
entropy change at 298K, they have different heat capacity changes (∆Cp).
It should be mentioned that we have found that the ∆H plots for binding these
diamidines to the d(GCGAATTCGC)2 duplex become curved at temperatures higher than
30 ºC (Figure 4.12). The observed ∆H values were found to be more negative than that
predicted by the low temperature results. It is possibly related to the heat of refolding the
pre-melted DNA (37). The UV thermal melting studies show that the melting point (Tm)
of free (A) AATT DNA duplex is 49 °C in MES20 buffer, and the binding of ligand
stabilizes DNA and increases Tm to 62 °C (Figure 4.13). Comparing the melting curves in
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Figure 4.11 Thermodynamic profiles of ∆G (square), ∆H (circle) and T∆S of binding
DB921 (red), DB911 (green) and DB1055 (blue) to AATT DNA in MES20 buffer as a
function of temperature.
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Table 4.4 Thermodynamic results for binding of aromatic diamidine compounds to
AATT DNA in MES 20 buffer at 25 °C.
∆G

∆H

T∆S

∆Cp

(kcal mol-1)

(kcal mol-1)

(kcal mol-1)

(cal mol-1K-1)

DB921

-11.5

-4.5

7.0

-175

DB911

-10.0

-2.5

7.5

-119

DB1055

-11.4

-4.2

7.2

-141

DB75*

-9.0

-2.2

6.8

-126

DB293*

-9.6

-3.6

6.0

-200

Compound

* ref. (31)
The errors for ∆G and ∆H are 10%, the fitting errors for ∆Cp are less than 5%.
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Figure 4.12 The plot of observed ∆H versus temperature for DB921 binding to
d(GCGAATTCGC)2 duplex. The black line is the best linear fitting over the temperature
range of 10-25 °C.
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Figure 4.13 Thermal melting profiles of d(GCGAATTCGC)2 duplex in the absence (red)
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the temperature range of 30-40 °C, it can be seen that some fractions of DNA are melted
at above 30 °C for free DNA and no DNA melting occurs between 30 - 40 °C for
DNA/DB921 complex. Therefore, it is possible that the pre-melted single-strand DNAs
fold back to duplex when titrating DB921 into DNA solution in the ITC experiments at
higher temperatures. In this case, the observed ∆H is the sum of heat of binding
interaction and heat of refolding DNA. To further test these estimations, titration of
DB921 into DNA was performed in higher salt concentration, MES50 buffer that
contains 0.5 M NaCl, at 30 °C and 25 °C. The ∆H value in MES50 at 30 °C is smaller
than that in MES20 as expected because DNA in the high salt is more stable. There is
almost no or very little unfolding at 30 °C. The ∆H value in MES50 at 25 °C is slightly
lower than that in MES20. These two data points are in agreement with the fitting line for
the range of 10 to 25 °C in MES20.
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Discussion
Three benzimidazole-biphenyl diamidines (DB921, DB911 and DB1055) have
different Tm values and biological activities although they are structural isomers and have
the same functional groups. The linear isomers surprisingly have stronger binding than
“classical” curved one. Detailed thermodynamic analysis of the three compounds was
carried out by combining SPR and ITC experiments. The thermodynamic analysis
provides a wealth of insight into the differences in binding constant, binding free energy,
energetic force for driving complex formation and energy contribution for the binding
interactions. SPR results clearly demonstrate that linear DB921 and meta-substituted
amidine isomer DB1055 have significantly higher binding affinities and thus more
favorable binding free energies (-∆G) than meta-substituted phenyl isomer DB911 at all
temperatures studied. The crystal structure of DNA/DB921 indicates that a bound water
plays an important bridging role for complex formation through forming hydrogen bonds
with both DB921 and DNA. SPR results also show that DB1055 preferentially interacts
with AT sequences than GC sequences. As described in Chapter 3, the comparison of the
crystal structure of DB921/DNA complex and the computer simulated structure of the
DB1055/DNA complex suggests the amidine group on the phenyl side of DB1055 takes
over the roles of bound water of the DB921/DNA complex. The amidine group of
DB1055 would form direct hydrogen bonds with AT base pairs in the minor groove in
such a complex.
The dependence of the binding constants of DB921 on salt concentration allows
us to investigate the electrostatic contributions to the interaction. The slope of the plot of
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logK vs logNa+ generates a zφ value of about 1.5 for the binding of DB921 to the AATT
oligomer duplex sequence. This value is somewhat low for two positive charges if φ is
used as 0.88 that is typical for long native B DNA. However, recently, it has been
reported that the φ value should be smaller for short oligomer DNAs due to their lower
charge density and less counter-ion release (32, 33, 35). Thus, both two charges on the
ends of DB921 form ion-pairs with phosphate groups of DNA under physiological
conditions. The φ value based on back calculation with z = +2 is about 0.75 under the
conditions here and it is good agreement with estimations for other short DNA oligomers
(32, 33, 35). The zφ value will be used below to evaluate the polyelectrolyte contribution
to total binding free energy.
The fact that all three compounds show little dependence of ∆G on temperature is
in consistent with other aromatic diamidines for binding in the minor groove. In contrast,
the enthalpy changes, ∆H, measured from ITC experiments at different temperatures for
all three compounds have a large dependence on temperature as illustrated in Figure 4.11,
and the variation of ∆H with temperature yields the heat capacity (∆Cp) for binding. The
plot of ∆H versus temperature may become curved at higher temperatures for some short
DNAs with low Tm. Increasing temperature may cause partial unfoldings of DNA, and
titration of ligand can cause premelted DNA to refold. As a result, the observed ∆H at
higher temperature is larger in magnitude than actual ∆H of binding interaction. ∆Hobs =
∆Hbinding+ ∆Hrefolding. The relationship between ∆H and temperature is still linear at lower
temperatures, and ∆Cp is derived from the slope of the linear fitting line in the low
temperature range. Also, it is possible to correct the heat effect of refolding using
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differential scanning calorimetry (DSC) (38) if ∆H values at higher temperatures are
needed in the case that compounds have low solubility at low temperatures.
The complete thermodynamic parameters (∆G, ∆H, T∆S, ∆Cp) shown in Table
4.4 reveal that the complex formation with DNA is mostly entropically driven for all
three compounds as found for other diamidine minor groove binders (18, 27, 39). All
three compounds show negative ∆Cp, which is typical for minor groove binders (18, 21,
27, 40). Importantly, it is clear that the stronger binding interactions of DB921 and
DB1055 to AATT DNA arise from more favorable ∆H compared to DB911 since all
three have very close T∆S values.
To evaluate the contribution of different components to the binding energetics, a
particularly useful equation of free energy distribution for DNA-ligand interactions is (11,
12):
∆Gobs = ∆Gconf + ∆Gt+r + ∆GPE + ∆Ghyd + ∆Gmol

(1)

where ∆Gconf is energy contribution from conformation changes during binding, ∆Gt+r is
the energy cost arising from loss of translational and rotational freedom on complex
formation, ∆GPE is the polyelectrolyte contribution , ∆Ghyd is the hydrophobic
contribution, and ∆Gmol is the contribution from molecular interactions. Minor groove
binding causes very little perturbation to DNA conformation, and the conformational
change contribution is considered as zero. For the term, ∆Gt+r , an empirical value of +15
kcal/mol for DNA-ligand binding is utilized (11). The polyelectrolyte term (∆GPE) arising
from the release of counterions from DNA upon binding cationic ligand in the minor
groove is evaluated by the formulation ∆GPE = zφRT ln[M+]. An experimental zφ value
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of 1.5 obtained from SPR salt dependence studies yields a ∆GPE value of –1.4 kcal/mol
for DB921 at 25 °C in MES20 buffer. The hydrophobic component (∆Ghyd) arises from
the hydrophobic transfer of the drug to the DNA minor groove. It can be estimated by an
empirical relationship with the heat capacity change (∆Cp), ∆Ghyd = 80 (±10) ∆Cp (11).
The molecular interaction term (∆Gmol) includes hydrogen-bonding, van der Waals
interaction and other non covalent molecular interactions between ligand and DNA.
∆Gmol can be calculated by equation (1) after free energy and other terms have been
quantified.
The complete distribution of free energy is summarized in Table 4.5. It should be
noted that the difference in binding energetics of DB921 and DB1055 can be parsed by
free energy contribution analysis although they have similar total free energy, same
binding driven force, and small distinguished energetics and entropic contribution to the
overall free energy. DB921 has more favorable hydrophobic contribution than DB1055.
The major contribution of strong binding of DB921 is the hydrophobic term while
DB1055 has a slightly higher contribution from molecular interactions. In contrast,
DB911 has a major contribution from molecular interaction. The larger contributions
from molecular interaction terms for DB911 and DB1055 probably arise from larger van
der Waals contact interactions due to their curved shapes that make them match the minor
groove better. The larger hydrophobic contribution for DB921 may be related to the
bound water. Dunitz and Cooper and coworkers have proposed the thermodynamic
contribution of a bound water is a lower entropy (∆(-T∆S): 0 to +2kcal/mol) and more
negative heat capacity change (∆(∆Cp): < -18 cal/mol K) (41-43). Because they are

130

Table 4.5 Free energy components of binding DB921 and its isomers to AATT DNA at
298K in MES20 buffer.
compound

∆Gobs

∆Gt+r

∆GPE

∆Ghyd

∆Gmol

DB921

-11.5

15

-1.4

-14.0

-11.1

DB911

-10.0

15

-1.4

-9.6

-14.0

DB1055

-11.4

15

-1.4

-11.8

-13.2
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structural isomers, it is interesting to explore the influence of bound water on DB921 by
comparing to DB911 and DB1055. The thermodynamic differences between DB921 and
DB911 fit well with Dunitz and Cooper’s theory as previously reported. The difference in
∆H and -T∆S values between DB921 and DB1055 are not obvious indicating that other
factors are involved. Nevertheless, significant difference in ∆Cp between DB921 and
DB1055 is observed. The heat capacity change of DB921 is more negative than DB1055
due to involvement of a bound water as predicted. This may explain why DB921 has
more favorable hydrophobic contribution to total free energy.
In conclusion, the complete thermodynamic analysis of three benzimidazolebiphenyl-diamidine compounds binding to DNA is informative. The complex formations
with DNA for three compounds are all predominantly entropically driven as other
cationic diamidine minor groove binders. The strong binding of both DB921 and DB1055
further supports that a bridge-functioned bound water is one of the pivotal factors for a
linear compound to obtain tight binding. Although DB921 and DB1055 have similar
binding free energies and energetic drive forces, the difference in energy contribution can
still be distinguished by quantifying each energetic term. DB921 has a more hydrophobic
contribution to binding free energy probably due to the bound water, which further
emphasizes the influence of the bound water for enhancing the binding affinity. More
favorable enthalpy changes of linear DB921 and DB1055 contribute to their tighter
binding interaction than “classical” curved DB911. These comparisons of their binding
energetics combined with structural information may provide useful information for full
understanding of their different biological processes.
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Chapter 5
Inhibition of DNA-Binding of an AT-Hook Peptide of HMGA by
Aromatic Dicationic Diamidines: Surface Plasmon Resonance Study

Introduction
The high mobility group A (HMGA) proteins are a family of non-histone
chromosomal DNA-binding proteins (1-4). The name HMG originated from their high
mobility in gel electrophoresis. HMGA proteins are unique transcription factors that
strongly bind to the narrow minor groove of AT-rich sequences in DNA duplexes. All
HMGA proteins contain three distinctive conserved DNA-binding domains (DBD1,
DBD2 and DBD3) called “AT-hooks” that preferentially bind to the minor groove of ATrich DNA sequences with four to six base pairs in length (5-8). The AT hook is a
versatile minor groove DNA binding domain that has a general sequence BBPRGRPBB
where the B is a positively charged amino residual (lysine or arginine), and the central
palindromic sequence, Pro-Arg-Gly-Arg-Pro (PRGRP), is referred to as an AT-hook
motif. The three AT hooks are separated by short amino-acid spacer segments. It has
been observed that the second DNA binding domain (DBD2) exhibits significantly higher
binding affinity than the first and third DNA binding domains (DBD1 and DBD3) and
plays an essential role in the interaction with the minor groove of AT-rich sequences (9).
The NMR solution structure of a HMGA DBD2 bound into d(GGGAAATTCCTC)2
DNA (9) shown in Figure 5.1 reveals that the RGR core of AT-hook motif fits deeply and
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Figure 5.1 The NMR structure of DBD2 bound to d(GGGAAATTCCTC)2 DNA duplex
(PDB: 2EZD) (9). The central core RGR of AT-hook motif PRGRP (shown in red) fits
well along the floor of the minor groove of DNA. The proline residues (shown in blue)
assist in force RGR to form a crescent shape to match the minor groove.
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suitably into the minor groove of an AAATT tract sequence site without substantial
perturbation in DNA conformation. The core AT-hook motif, RGR, adopts a specific
crescent conformation to obtain optimal contact interactions with the minor groove when
binding to DNA (9, 10). The trans- proline residues of PRGRP facilitate insertion of two
arginine residues along the floor of the minor groove of AT sequence DNA. The central
RGP core makes significant hydrogen-bonding interactions with AT basepairs on the
floor of the minor groove, while the flanking lysine and arginine residues at the terminals
of PRGRP contribute electrostatic interactions with DNA phosphates on the DNA
backbone and hydrophobic interactions of aliphatic methylenes of the side chains with
adenine or thymine bases of DNA.
HMGA proteins act as architectural transcription factors and play critical roles in
many cellular processes such as regulating the transcription of cellular and viral genes,
modeling chromosome structure and enhancing cell transformation and differentiation (1,
2, 11, 12). Importantly, HMGA protein expression is barely detected in normal adult
somatic cells in contrast to their high expression during the early stages of embryonic
development (1, 3, 6). High levels of expression of HMGA proteins, however, have been
observed in a number of tumor cells including thyroid, pancreatic and breast cancers (1,
3). Considerable studies have shown that the over-expression of HMGA proteins in the
adult cells is associated with transformation and metastatic progression of neoplastic cells
and the expression level exhibits a correlation with the degree of malignant
transformation (13, 14). Therefore, HMGA proteins could be utilized as a promising
biomarker for cancer detection.
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Inhibition of specific transcriptional regulatory proteins is a promising strategy for
regulating gene expression (15, 16). Transcriptional activity of DNA-binding proteins can
be blocked by the use of inhibitors that compete for the binding to their specific targeting
sequences in promoters and enhancers (17-21). In the same manner, it is possible to
eliminate the related tumor progression in the living cells by inhibition of HMGA protein
expression. Moreover, HMGA protein selectively recognizes AT-rich binding sites and
strongly binds in the minor-groove of DNA through three HMGA AT hooks. This unique
characteristic of HMGA offers great opportunities for rational design of AT minor groove
binders to achieve anti-cancer or anti-viral activity through competition with HMGA
proteins for binding to the same AT-rich binding site in the DNA promoter region and
thus inhibiting the HMGA expression.
Furamidine, DB75, has exhibited excellent antiprozoal activity through
interaction with the minor groove of AT DNA sequence (22-24). As part of efforts to
develop new compounds with enhanced activity or new biological activities, a set of
derivatives of furamidine have been synthesized and studied (25, 26) (Figure 5.2). In the
previous structure-affinity relationship studies (Chapter 3), we have found that linear
biphenyl-benzimidazole diamidine, DB921, has a significant tight binding affinity to AT
sequence in the minor groove via the support from water-mediated interaction despite of
lack of crescent curvature. Its meta-amidine isomer DB1055 also shows strong binding
while its curved meta-phenyl isomer DB911 has a 10 times weaker binding affinity.
DB1302, a methyl- benzimidazole analogue of DB921, has 100 times lower binding
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affinity due to loss of a hydrogen-bond donor on the benzimidazole ring. Since these
compounds all specifically bind to the minor groove of the AT-rich sequences of DNA,
they have the potential to inhibit the interaction between HMGA protein and DNA by
competing with the protein for binding to the same target sequence of DNA.
Although the inhibition of HMGA1 protein, one protein of the HMGA family,
was studied by gel mobility shift (27, 28) more than twenty years ago, more detailed
information obtained by direct optical methods for the inhibition studies of HMGA
proteins are still limited. Direct spectroscopic studies are difficult since the AT-hook
peptides of HMGA do not contain intrinsic chromophores such as tryptophan or tyrosine.
Labeling the peptides with specific probes has the potential risk to interfere with the
interactions between these peptides and DNAs. In this chapter, we report the preliminary
studies on inhibition of HMGA-DNA interactions by AT-minor groove binders, aromatic
cationic diamidine analogues (Figure 5.2), using biosensor-surface plasmon resonance
(SPR) technology. Biosensor-SPR technology allows us to monitor and study
biomolecular interactions in real time, without labeling any of the interacting components.
Valuable information concerning binding specificity, and quantitative binding affinity
and kinetics can been obtained using SPR (29-35).
In an effort to achieve our long-term goal, inhibition of HMGA protein expression
by small molecules for the rational design and development of anticancer and antiviral
drugs, we started an initial study of competitive binding of small molecules with one AThook model system of HMGA. We wanted to understand the basic inhibition mechanism
for a single AT-hook peptide before moving to the complicated competition and
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inhibition of the full protein that contains three AT-hooks. Kinetics is one of most
significant factors that need to be explored and it is a key factor for governing the
inhibition activity. Inhibitors with very slow inhibition kinetics probably will not be able
to effectively exert their activities in the biological processes even if they have strong
binding affinities for the target site. Therefore, it is essential to perform direct
competition studies of inhibitors with the peptide model system for binding to the same
site of target DNA to probe the both affinity and kinetics of drug during the competition.
In the studies reported here, a peptide-DNA model system consisting of the
second AT-hook (DBD2) peptide of HMGA1 protein and a DNA oligomer similar to the
PRD-II element of the interferon-β gene (IFN-β) promoter was utilized (Figure 5.2). The
PRD-II site containing an AT-tract of five base pairs is the specific binding site in the
promoter region of the human IFN-β gene (9), one of the important genes activated by
HMGA1 protein in vivo (36, 37). Firstly, the binding interactions between DBD2 and the
DNA model of PRD-II site were characterized using biosensor-SPR technology. Then,
SPR competitive binding experiments of aromatic amidine analogs (Figure 5.2) with an
AT-hook of HMGA to its target DNA were evaluated and compared. The inhibitory
effect and kinetics of these drugs for inhibiting the binding interaction of DBD2 peptide
to DNA were probed. A new inhibition experimental methodology was explored and
built for our long term goal, inhibition of the interaction of HMGA with the target DNA
for regulation of HMGA expression.
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Materials and Methods
Materials and apparatus
DB compounds were synthesized by Dr. David W. Boykin and coworkers. 5’Biotin labeled hairpin DNA oligomer from Midland Certified Reagent Co. (Midland, TX)
was utilized for SPR study. DBD2 peptide with an acetylated N-terminal and an amidated
C-terminal was purchased from AnaSpec, Inc. (San Jose, CA). MES 10 buffer containing
0.01 M MES, 0.001M EDTA and 0.1 M NaCl with an adjusted pH of 6.25 was used for
all experiments. An amount of 0.005% (v/v) BIA certified surfactant P-20 was added into
MES10 buffer for biosensor SPR studies to minimize the nonspecific absorption to the
autosampler tube and the IFC channels.
Surface plasmon resonance experiments were carried out using a Biacore 3000
instrument (Biacore AB, Uppsala, Sweden). CM5 sensor chips with a carboxymethylated
dextran matrix and an amine coupling kit containing N-hydroxysuccinimide (NHS) and
N-ethyl-N’-(dimethylaminopropyl) carbodiimide (EDC) and ethanolamine hydrochloride,
were obtained from Biacore AB.
Thermal melting experiments
Thermal melting experiments of poly(dA)·poly(dT) with compounds were
performed using a Cary Bio 300 instrument as described in Chapter 3.
Immobilization of DNA
5’-biotin labeled DNA was immobilized after the immobilization of streptavidin
on a CM5 sensor chip. The CM5 sensor chip was first activated by injecting a fresh
mixture of 50 mM NHS and 200 mM EDS at a rate of 5 µl/min. A 400 µg/ml of
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streptavidin in 10 mM acetate buffer was then injected until around 3000 RU of
streptavidin was obtained. The excess and non-covalently bound esters were removed by
injection of 1M ethanolamine hydrochloride, followed by flowing running buffer. The 5’Biotin labeled DNA hairpin was then immobilized on the sensor chip surface via biotin
capture by streptavidin as described in previous chapters.
SPR Binding experiments
The DBD2 peptide samples were prepared into different concentrations with
degassed and filtered MES10 buffer containing 0.005% (v/v) BIA certified surfactant P20, which was also used as the running buffer and regeneration buffer. To study the
binding interaction between the DBD2 peptide and AT DNA, various concentrations of
DBD2 peptide samples were passed over the immobilized DNA surface followed by the
running buffer injection to measure the dissociation. The binding curves were analyzed
using a one-site or two-site steady-state models as in previous chapters to acquire binding
affinity. Kinetics was obtained by globally fitting the data at lower concentrations with
1:1 Langmuir binding model.
SPR Competitive binding experiments
The samples containing the a fixed concentration of DBD2 peptide and varied
concentrations of the inhibitor in MES10 buffer were injected over the immobilized DNA
surface at 30 µl/min, followed by injection of running buffer, MES10 buffer. Two times
1-min running buffer injections were used for the surface regeneration. The binding
interaction curves were analyzed using the heterogeneous analyte competition model
provided by the Biacore 3000 evaluation software version 4.1 to determine the binding
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rate constants and binding affinity for each inhibitor under the competition with the
DBD2 peptide. The rate equations for heterogeneous analyte competition model are
described as follows:
A1+B ↔ A1B
A2+B ↔ A2B
B[0] = Rmax/mw1
dB/dt = -(ka1*A1*mw1*B - kd1*A1B)/mw1*n1 - (ka2*A2*mw2*B - kd2*A2B)/mw2*n2
A1B[0] = 0
dA1B/dt = (ka1*A1*mw1*B - kd1*A1B)
A2B[0] = 0
dA2B/dt = (ka2*A2*mw2*B - kd2*A2B)
Total response:
A1B + A2B + RI
where A1 and A2 are concentrations of analyte 1 and analyte 2 respectively, B is the
concentration of the immobilized DNA, A1B is the concentration of the complex formed
by A1 and DNA, A2B is the concentration of the complex formed by A2 and DNA, mw1
and mw2 are the molecular weights of A1 and A2 respectively, n1 and n2 are the number
of binding sites blocked by A1 and A2 respectively, ka1 and kd1 are the association and
dissociation rate constant for A1, ka2 and kd2 are the association and dissociation rate
constant for A2, Rmax is the total binding capacity of A1 and A2, and RI is bulk
refractive index effect. This competition model is suitable for two molecules, especially
for one with a high molecular weight and another with a low molecular weight,
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competing for the same binding site on the target. In our case, A1 is the AT-hook peptide
of HMGA and A2 is the synthetic inhibitor.

Results
Binding of DBD2 to DNA
In an attempt to explore the inhibition of the binding interaction of HMGA and
DNA by small molecules, it is essential to understand the interaction first. To evaluate
and compare the binding of HMGA1 DBD2 peptide to AT DNA sequence with the minor
groove binders (Figure 5.2), we performed thermal melting studies of DBD2 with
poly(dA)·poly(dT) and SPR binding experiments with a 5’biotin-labeled AATT DNA
hairpin containing four AT basepairs. These DNAs were initially used because they have
been studied with a large number of minor-groove-binding compounds. Figure 5.3 shows
the plot of the first derivatives of absorbance with respect to temperature against
temperature for poly(dA)·poly(dT) in the absence and presence of HMGA DBD2 peptide
in MES10 buffer. The DBD2 peptide increases the stability of the poly(dA)·poly(dT) by a
∆Tm value of 12.4 °C, which is lower than the ∆Tm values of DB921 (>28 °C), DB1055
(>28 °C), DB911 (19.8 °C) and DB1302 (17.8 °C) as reported in Chapter 3. The SPR
binding experiment of DBD2 with AATT DNA (Figure 5.4A) confirms the weaker
binding of DBD2 peptide with a binding constant (KA) of 5.9 ×105 M-1 compared with
DB921 (7.0 ×108 M-1), DB1055 (6.2 ×108 M-1), DB911 (5.1 × 107 M-1) and DB1302 (5.3
×106 M-1).

149

0.2

poly(dA).poly(dT)
0.15

dA/dT

DBD2/poly(dA).poly(dT)

0.1

0.05

0

20

30

40

50

60

70

80

90

100

T (°C)

Figure 5.3 The plot of the first derivatives of absorbance with respect to temperature
against temperature for poly(dA)·poly(dT) in the absence and presence of HMGA DBD2
peptide in MES10 buffer. A molar ratio of 0.3 peptide per DNA base was used for
DBD2/DNAcomplex.
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Figure 5.4 SPR sensorgrams for binding interactions between DBD2 peptide and
(A)AATT DNA and (B) AATTT DNA, respectively, at 25 °C in MES10 buffer. The
concentration ranges from the bottom to the top curves are (A) 0.1, 0.3, 0.5, 0.7, 0.9 and
1.0 µM; (B) 0.05, 0.075, 0.15, 0.25, 0.5, 0.75 and 1.0 µM. The black solid curves are the
best global fitting curve with 1:1 Langmuir binding model.

151

SPR binding experiments with a 5’biotin-labeled AATTT DNA hairpin containing a fivebase-pair AT tract similar to the target sequence in the PRD-II element of the IFN-β gene
promoter for DBD2 AT-hook were conducted to quantitatively characterize the binding
interaction of DBD2 peptide to the biological AT DNA target site. After averaging the
response at steady state and converting it to r (moles of bound compound per mole of
DNA hairpin) for each concentration, r values were plotted as a function of concentration
as shown in Figure 5.5. The data were then fitted with a non-linear two site steady-state
binding model. The results clearly show that there are some non-specific binding
interactions in addition to the first stronger specific binding interaction. The DBD2
peptide has a binding affinity of 2.5 ×106 M-1 (KA1) for the AT binding site. At higher
concentration, DBD2 peptide non-specific interactions probably occur with the phosphate
groups on the DNA backbone through the multiple positively charged residues of the
peptide. To study the kinetics at the specific AT binding site, only low concentration
curves on the binding sensorgram were selected for global kinetic fitting as shown in
Figure 5.4B. The binding affinity obtained for the ratio of rate constants is consistent with
KA1 from the steady-state binding model. The binding affinities and kinetics with
different AT DNAs are summarized in Table 5.1. These SPR binding studies provide
valuable information for further inhibition studies.
Competitive binding assay
As noted in the Introduction, it is important to carry out direct competitive
binding studies of potential drugs and the peptide with the DNA biological target site.
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Figure 5.5 Binding curve for the interaction of DBD2 peptide with AATTT DNA in
MES10 buffer at 25ºC The black line is the best fitting curve using a two-site steady-state
binding model (see Materials and Methods.)
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Table 5.1 Binding affinities and kinetics for the interactions of DBD2 peptide with AT
DNAs
Term

poly(dA)·poly(dT) AATT DNA

AATTT DNA

∆Tm (°C)a

12.4

-

-

ka (M-1s-1)b

-

6.6 ×104

1.8 ×105

kd (s-1)b

-

0.13

0.077

KA kin (M-1)c

-

5.1 ×105

2.3 ×106

KA eq (M-1)d

-

KA1: 5.9 ×105

KA1: 2.5 ×106
KA2: 1.4 ×105

Note. All experiments were performed in MES10 buffer. SPR experiments were
conducted at 25 ºC. The fitting errors are 5 - 10% and experimental are 15 - 20%.
a

Determined from ∆Tm = Tm complex – Tm DNA.

b

Determined from global kinetics fitting of low concentration responses with a 1:1

Langmuir binding model.
c

Determined by KA kin = ka / kd

d

Determined from the best fitting of r versus concentration with one-site or two-site

steady-state binding model (see Materials and Methods).

154

The competitive binding studies were conducted by injection of samples containing a
constant concentration (1µM) of DBD2 peptide and varied concentrations of inhibitors,
aromatic amidines, over the surface of immobilized AATTT DNA. The inhibitor
competes with DBD2 peptide for binding to the AT site of DNA.
Figure 5.6A presents a typical SPR competitive binding sensorgram for DB1055
competition with the DBD2 peptide. The top curve is 1 µM peptide alone; the bottom
curve is the 1 µM DB1055 only. As can be seen, the SPR signal decreases on increasing
the concentration of DB1055 as expected due to binding from the lower-molecularweight DB1055. The sensorgram signal becomes stable when the concentration of
DB1055 is about 0.1 µM, indicating that the binding site is close to saturation with bound
DB1055. This also can be visualized in the plot of normalized RU versus concentration
of DB1055 in the presence of the peptide in Figure 5.6B. However, a gap between the
saturation of binding site with DB1055 in the presence of DBD2 peptide and in the
absence of peptide is observed (Figure 5.6A). The higher RU signal for saturation of
DB1055 in the presence of DBD2 peptide could be due to the contribution of some
nonspecific binding from the peptide during the competition, although DB1055 displaces
all peptides in the AT binding site during competition. In addition, there is a very unique
“increase-decrease-plateau” in the RU response in the association part of competition
binding sensorgram. This could be explained by fast association kinetics of DBD2
peptide (see Figure 5.4) and slow observed association kinetics for DB1055 with some
peptide dissociation. Firstly, the high-molecular-weight peptide with fast association
kinetics quickly binds to the interaction site of DNA and produces an increase in RU
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Figure 5.6 (A) SPR sensorgram of the competitive binding interaction of DB1055 and
DBD2 peptide to AATTT DNA in MES10 buffer at 25 ºC. Top curve: 1µM DBD2 only;
Bottom curve: 1 µM DB1055 only; Middle curves: 0.0002-1 µM (from the up to down)
of DB1055 in the presence of a constant concentration of 1 µM DBD2 peptide. (B) The
plot of normalized RU versus the concentration of DB1055 in the competitive binding
experiments.
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Figure 5.6(C) SPR sensorgram of the competitive binding interaction of DB1055 and
DBD2 peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the
top to the bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.001 µM DB1055, 1 µM
DBD2 / 0.002 µM DB1055, 1 µM DBD2 / 0.003 µM DB1055, 1 µM DBD2 / 0.005 µM
DB1055, 1 µM DBD2 / 0.01 µM DB1055 and 1 µM DBD2 / 0.04 µM DB1055. The
black lines are the best fitting lines using the heterogeneous analyte competition model.
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response. As low-molecular-weight DB1055 displaces the peptide to bind in the
interaction site, a decrease in RU response is observed. Finally, at equilibrium, the (A)
binding of DB1055 blocks the interaction of the DBD2 with the specific site of DNA,
which is responsible for the plateau of RU responses. It is very obvious that DB1055
displaces the peptide rapidly during the competition. Figure 5.6C shows the selected
sensorgram curve for global fitting using the heterogeneous analyte competition model
for determination of binding kinetics of DB1055 in the presence of competition of 1µM
DBD2.
The competition binding sensorgram with competition fitting curves for DB921,
DB911 and DB1302 with DBD2 peptide to AT DNA are shown in Figure 5.7, Figure 5.8
and Figure 5.9, respectively. The competitions of the dicationic minor groove binding
compounds, netropsin and berenil with DBD2 were also explored for comparison (Figure
5.10 and Figure 5.11). Binding affinities and kinetics are listed in Table 5.2. The kinetics
of DB1302 and berenil are too fast to determine under these experimental conditions. The
amidines with higher binding affinities with AT DNA have the stronger binding
competition with the DBD2 peptide. DB921 and DB1055 have tighter binding and
different kinetics compared with DB911 and DB1302. The displacement of the peptide is
quite rapid for all compounds. Additionally, the difference between the increased
concentrations of the compound and DBD2 alone can be distinguished during the
dissociation phase. Increasing the concentration of the compound converts the fast
dissociation kinetics for the peptide to the slow dissociation kinetics for the compound.
This suggests that the compounds and the peptide compete for the same binding site.
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Figure 5.7 SPR sensorgram of the competitive binding interaction of DB921 and DBD2
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.0005 µM DB921, 1 µM DBD2 /
0.002 µM DB921, 1 µM DBD2 / 0.004 µM DB921, 1 µM DBD2 / 0.01 µM DB921 and 1
µM DBD2 / 0.04 µM DB921. The black lines are the best fitting lines using the
heterogeneous analyte competition model.
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Figure 5.8. SPR sensorgram of the competitive binding interaction of DB911 and DBD2
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.002 µM DB911, 1 µM DBD2 /
0.01 µM DB911, 1 µM DBD2 / 0.02 µM DB911, 1 µM DBD2 / 0.04 µM DB911, 1 µM
DBD2 / 0.1 µM DB911 and 1 µM DBD2 / 0.6 µM DB911. The black lines are the best
fitting lines using the heterogeneous analyte competition model.
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Figure 5.9. SPR sensorgram of the competitive binding interaction of DB1302 and DBD2
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.01 µM DB1302, 1 µM DBD2 /
0.15 µM DB1302, 1 µM DBD2 / 0.2 µM DB1302, 1 µM DBD2 / 0.8 µM DB1302 and
1µM DBD2 / 1 µM DB1302. The black lines are the best fitting lines using the
heterogeneous analyte competition model.

161

DBD2 peptide_Netropsin_AATTT_MES10

RU
45

40

35

30

Resp. Diff.

25

20

15

10

5

0

-5

-10
400

600

800

1000

1200

1400

1600

1800

Tim e

s

Figure 5.10. SPR sensorgram of the competitive binding interaction of netropsin and
DBD2 peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the
top to the bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.0005 µM netropsin, 1
µM DBD2 / 0.001 µM netropsin, 1 µM DBD2 / 0.004 µM netropsin, 1 µM DBD2 / 0.01
µM DB netropsin, 1 µM DBD2 / 0.05 µM netropsin and 1 µM DBD2 / 0.1 µM netropsin.
The black lines are the best fitting lines using the heterogeneous analyte competition
model.
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Figure 5.11 SPR sensorgram of the competitive binding interaction of berenil and DBD2
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.004 µM berenil, 1 µM DBD2 /
0.02 µM berenil, 1 µM DBD2 / 0.06 µM berenil, 1 µM DBD2 / 0.1 µM berenil, 1µM
DBD2 / 0.4 µM berenil and 1µM DBD2 / 1 µM berenil. The black lines are the best
fitting lines using the heterogeneous analyte competition model.
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Table 5.2 Kinetics and binding affinities of compounds in SPR competitive binding
experiments with DBD2 peptide
Compound

ka (M-1s-1)

kd (s-1)

KA kin (M-1) *

DB921

2.4 ×106

3.4 ×10-3

7.1 ×108

DB1055

1.9 ×106

3.7 ×10-3

5.1 ×108

DB911**

Too fast

Too fast

-

DB1302**

Too fast

Too fast

-

Netropsin

5.8 ×106

2.4 × 10-3

2.4 ×109

Berenil**

Too fast

Too fast

-

Note. All experiments were performed in the presence of 1 µM DBD2 peptide in MES10
buffer at 25 ºC. The rate constants were determined using heterogeneous analyte
competition model (see Materials and method).
* KA = ka / kd
** The interaction kinetics of DB911, DB1302 and berenil in the presence of DBD2
peptide are too fast to determine under these experimental conditions.
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Although the observed RU signal in the SPR competitive binding experiment is
not exactly from the binding of the peptide but the sum of the peptide and small molecule,
the influence of binding from the lower-molecular-weight small molecule on the total RU
signal compared with the predominant higher-molecular-weight peptide is considered to
be negligible for only qualitatively ranking the inhibitory effect. To better visualize the
inhibitory effect of these compounds to the interaction of DBD2 peptide and its target
DNA, the observed SPR response from the DBD2 peptide binding to DNA were
normalized by setting the top point (DBD2 alone) as 100% peptide bound to the specific
site and the bottom point (maximum concentration of inhibitor, no specific binding from
DBD2), where the signal stops dropping, as 0% peptide as shown in Figure 5.12. The
relative inhibition effects can be easily viewed. To relatively rank the inhibitory effect,
the observed IC50 values were estimated by a non-linear regression equation and reported
in Table 5.3. It is clear that netropsin, DB921 and DB1055 have remarkably efficient
inhibition effects in agreement with their strong binding to AT sequence. The ranking
order of amidine inhibitory effects, DB921/DB1055 > DB911 > DB1302, is consistent
with the order of the binding affinity to the DNA. All compounds rapidly displace the
peptide from the binding site.
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Figure 5.12 Comparison of the plots of normalized RU versus the concentrations of
small-molecule inhibitors in SPR competitive binding experiments with 1 µM DBD2
peptide (see Materials and Methods).
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Table 5.3 The observed IC50 values of compounds in SPR competitive binding
experiments with DBD2 peptide
Compound

IC50 observed (nM) *

DB921

5.0

DB1055

5.2

DB911

41

DB1302

140

Netropsin

1.6

Berenil

85

Note. All experiments were performed in the presence of 1 µM DBD2 peptide in MES10
buffer at 25 ºC.
* The observed IC50 value estimated from the plot of normalized RU versus
concentration for ranking the inhibitory effect. The fitting errors are < 8%.
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Discussion
HMGA proteins are important regulatory proteins that selectively bind to the
minor groove of AT DNA sequences through three AT hooks. Inhibition of the
interaction between HMGA and DNA by AT minor groove binders is an attractive
approach for regulating gene expression (1, 3). SPR has been used to study a model
system consisting of a second DNA-binding domain (DBD2) of HMGA, the most
important AT hook, and a DNA oligomer containing a five-base-pair AT-tract similar to
the binding site in IFN-β gene promoter region for DBD2. A set of AT minor grove
binders, aromatic cationic diamidines, were utilized for competitive binding studies with
DBD2 peptide.
Binding studies for the interaction of DBD2 with AT DNAs demonstrate that
DBD2 has a weaker binding compared to these diamidines, reflected by ∆Tm values from
thermal melting experiments and KA values from SPR experiments. These results suggest
that these compounds could block the binding interaction of DBD2 peptide with its target
AT DNA by competition since they have higher binding affinity and AT preference.
It has been shown that the AT-hook motif core, RGR, in the DNA complex
mimics the conformation of netropsin. As expected, netropsin blocks the binding site
after competitively binding and shows efficient inhibition of the binding of HMGA due
to its strong binding affinity and the structural similarity with the AT-hook core. In
previous chapters, we reported that DB921, a linear biphenyl-benzimidazole diamidine,
gains a tight binding to the minor groove of AT-rich DNA sequence through watermediated interaction. An important question is whether it can block the binding of
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HMGA to DNA with efficient inhibition without a crescent shape similar to the RGR
core of AT hook. Here, we used SPR technology to study the inhibition effects of DB921
and its analogues using a competitive binding assay to answer this question.
It was observed that SPR signals gradually decrease on enhancing concentrations
of DB921 during the competition with the peptide. This is also true for other diamidines,
and the SPR signals decrease at different concentrations for different compounds
depending upon their binding affinities. The DBD2 peptide has a significantly higher
molecular weight than those of inhibitors, and the SPR signal is proportional to the mass
on the sensor surface. As a result, the SPR signals with increased concentrations of the
inhibitor will drop until the binding site is saturated with the inhibitor if two competitors
bind to the same binding site. The SPR results obtained confirm that DBD2 peptide and
these AT minor groove binders complete for binding to the same site of DNA. The fact
that the RU signal is higher when the specific binding site is saturated with the compound
in the presence than that in the absence of the competition of the DBD2 peptide reveals
that the compound displaces the peptide in the specific binding site but not the nonspecific binding site. This is the first observation of this type of competition.
Important kinetics information and inhibition rates were also obtained by these
studies. It should be noted that an “increase-decrease-plateau” characteristic has been
observed on the association parts of the competitive binding sensorgrams for DB1055
and DB921. As described in the Results Section, this effect is probably related to the
competition between the amidine and the peptide with quite different kinetics (38).
DBD2 has a very fast association kinetics as shown in Figure 5.4 while DB921 and
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DB1055 have slow observed association kinetics at the concentrations needed to displace
the peptide. One hypothesis is that DBD2 with fast kinetics binds quickly to the binding
site, and then DB921 or DB1055 displaces the binding of the peptide and blocks the
binding site for the peptide. It can be seen that the displacement of the peptide by these
compounds is rapid. In addition, on the dissociation phase of the sensorgram, the kinetics
becomes more close to the slow kinetics of DB921 from the fast kinetics of the peptide
when increasing concentration of DB921, which supports that DB921 and DBD2
compete for binding at same site.
SPR competitive binding experiments also provide information about the
qualitative ranking of inhibition effect. The results show that these aromatic diamidines
inhibit the binding interaction of DBD2 peptide with different efficiencies as a relative
ranking order: DB921 / DB1055 > DB911 > DB1302. This ranking order is in good
agreement with the order of binding affinity, which reveals that the compounds with
higher binding affinities and specificities could have more efficient inhibitory effects.
The quantitative inhibitory effect, IC50 value (inhibitory 50%), could be achieved by
injecting the same concentration series containing only compound and then subtracting
these signals from the total RU signal. The IC50 values can be determined by plotting the
net signal from binding of DBD2 as a function of the concentration of the inhibitor and
then fitting the data with the non-linear regression equation. DB921 has an excellent
inhibitory effect like netrospin on blocking the interaction between DBD2 and its target
DNA. These results show that the DB921, which does not have a similar structural
conformation to AT-hook motif is still an excellent inhibitor. The bound water probably
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also plays an important role for the inhibition effect of linear DB921 in the similar
manner as for the strong binding. The studies reported here show that DB921 and
DB1055 are promising efficient inhibitors for the interaction of HMGA with AT-rich
DNA.
In conclusion, direct competitive binding studies of a set of amidines and the
DBD2 peptide with the biological target DNA using biosensor-SPR offer significant
information regarding inhibition. First of all, these AT minor groove binders, diamidines,
demonstrate the expected inhibitory effects. They compete with the peptide for binding to
the same site of the minor groove of AT DNA, and block the binding interaction of the
peptide after they bind to DNA. The ranking order is consistent with their binding
affinities. Secondly, the amidines show a very fast rate for inhibition of the binding of
DBD2 peptide to the DNA, which is essential for their biological activities. Thirdly, these
inhibitors may only block the specific AT binding of the peptide without inhibition of its
non-specific binding interaction. The studies reported in this Chapter provide critical
information and build a new experimental method for later further study of the inhibition
of HMGA proteins and regulation of gene expression by AT minor groove binders.
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